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ABSTRACT 
 
 
 
The subject of acquisitions is one of great complexity, and most acquisitions are considered unable 
to deliver to the expectations of the acquirer, which has led to a lot of research being undertaken on 
the subject. For many firms, the choice to venture into the field of mergers and acquisitions is 
regarded as the strategically most important decision they will ever undertake. According to several 
researchers, how a firm is integrated is the single most important factor to the acquisitions success 
and an acquisition that is not properly integrated in regards for the motives for the acquisition are 
more likely to fail. Understanding what synergies the firm wishes to acquire with the acquisition is 
paramount in these decisions, and in deciding how the acquired firm will be integrated. The purpose 
of this dissertation was therefore to investigate how a firm handles the integration-choices of an 
acquisition based on the motivations behind it and the synergies sought. 
 
The theoretical framework consisted of the underlying motivations of an acquisition, the structural 
integration that would follow from those motives, the describing characteristics of the industry, and 
a theoretical formula combining structural and informal integration required to meet the needs of 
coordination. The ideas for structural integration were combined with this formula in order to have 
a more firm basis for the structural integration and utilize the informal integration to explain certain 
other factors. The different ways an acquiring firm must keep the factors of a technology acquisition 
or an acquisition of knowledge in mind are also outlined, since there are certain additional factors 
affecting the process. 
 
The empirical data was gathered through a qualitative approach in a semi-structured interview with 
the chief of operations of Getinge Infection Control. The data acquired was complemented through 
the usage of information from corporate websites, industry-studies and scientific articles, most 
notably a master's dissertation outlining Getinge AB's usage of acquisitions in their 
internationalization process. 
 
The findings of this thesis is that the manners of structural and informal integration affect the 
coordination capacity, and that the nature of the industry affects how these factors sum up to form 
the coordination capacity. The acquisition of highly technical stand-alone products for the 
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innovative capabilities must be treated with care, as structural integration may damage the 
innovative capabilities that were desired. The thesis highlights the need for informal integration in 
these cases. The findings also present that, when properly executed, there are not reasons why 
problems should be observed, even in the acquisitions of highly technically complex firms. 
 
 
Keywords: integration, post-acquisition, acquisition motives, structural integration, informal 
integration, culture, industry, MedTech, technology acquisition, market entry, role of industry in 
acquisitions, technology, Porter's five forces, Getinge AB, Getinge Infection Control, La Calhène. 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
5 
 
 
 
 
TABLE OF CONTENTS
1. INTRODUCTION ...................................................................................................................... 7 
1.1 Background .................................................................................................................................. 7 
1.2 Problem and Focus ..................................................................................................................... 10 
1.3 Purpose ...................................................................................................................................... 10 
1.4 Delimitation ............................................................................................................................... 10 
1.5 Disposition ................................................................................................................................. 11 
2. THEORETICAL FRAMEWORK .................................................................................................. 13 
2.1 The Industry and Its Implications ................................................................................................. 13 
2.2 Post-Acquisition Integration ........................................................................................................ 14 
2.3 Conclusion of Theoretical Framework .......................................................................................... 22 
3. METHODOLOGY .................................................................................................................... 24 
3.1 Research Approach ..................................................................................................................... 24 
3.2 Validity and Reliability ................................................................................................................ 25 
3.3 Case Study .................................................................................................................................. 25 
4. EMPIRICAL FINDINGS ............................................................................................................ 28 
4.1 The MedTech Industry ................................................................................................................. 28 
4.2 Getinge AB's Basic Information ................................................................................................... 29 
4.3 La Cahene's Basic Information ..................................................................................................... 31 
4.4 The Integration of La Calhène Into Getinge IC .............................................................................. 31 
5. ANALYSIS .............................................................................................................................. 34 
5.1 Industry Analysis ........................................................................................................................ 34 
5.2 Analysis of Degree of Integration ................................................................................................ 36 
5.3 Analysis of Informal Integration .................................................................................................. 38 
5.4 Analysis of the Acquisition of La Calhène Relative Getinge AB's Previous (and Subsequent) 
Acquisitions ..................................................................................................................................... 39 
5.5 Analysis of the Impact of Industry on the Acquisition Decisions .................................................... 40 
6. CONCLUSIONS ...................................................................................................................... 41 
6.1 General Conclusion ..................................................................................................................... 41 
6.3 Managerial implications ............................................................................................................. 44 
6.4 Recommendations For Future Research ....................................................................................... 44 
7. REFERENCES ......................................................................................................................... 46 
APPENDIX I: INTERVIEW GUIDE ................................................................................................ 52 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
6 
 
APPENDIX II: GETINGE’S ACQUISITIONS .................................................................................... 54 
 
 
 
 
 
 
 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
7 
 
 
 
1. INTRODUCTION 
 
This chapter will present the general background of the thesis,  
that is the different types of acquisitions and their motives, the  
possible problems of the implementation-process and how to  
avoid them. Also, the problem and the purpose of this study  
will be clarified. 
 
1.1 Background 
The concept of mergers and acquisitions has been researched for many years, much due to the complex 
nature of merging two autonomous organizations into one unit (Kitching 1967; Huang & Wang 2010). 
Whether it is a small firm being engulfed by a larger firm, or a merger of two equal firms, the process is 
complicated and is not always successful. A study made by famous consulting firm KPMG (1999) shows that 
of the benefits anticipated, in general only 75 % where attainable, and another study made by Jennings 
(1985) showed that over 70 % of the acquisitions studied failed to meet expectations. There are also a few 
nightmarish scenarios, such as Daimler-Benz's 1998 acquisition of Chrysler, which went from being the 
hottest automaker in USA to wiping out $60 billion in market value (Arndt M., Thornton E., Foust D., 2000). 
All this points towards the same issue, in spite of the time that passed in between the two studies: 
acquisitions are complex and require serious attention and planning in order to make a success more 
probable (Jennings 1985).  
 
Global corporations are a growing phenomenon, and a previous studies show that 76 % of the respondents 
mentioned that access to new markets was a driving reason for acquisition (Spratt & Feldman 1999). Fletcher 
and Barret (2007) also notes that acquisitions have been used more frequently as a vehicle for expansion of 
commercial activities in a firm's international involvement, which Huang and Wang (2010) concludes 
implies a far-reaching emergence of acquisitions by MNC:s (Multinational Companies). Nancy Hubbard 
(2001) also found, based on the studies of Spratt and Feldman, that there are two primary reasons for 
acquisitions; personal & political and strategic. Another study showed that 31 % of all respondents confessed 
that the most important reason for their previous acquisition was either political or personal (Hubbard 2001; 
Hunt & Turner 1987). This implies that there is a large impact of personal and political factors on the 
acquisitions decisions, which is a fact that is in contrast to the manner in which corporations are generally 
perceived, that is as entities that act based on cost-benefit reasons alone. While the study shows that personal 
and political reasons are important to the decisions taken, it also shows that 69% of the respondents 
considered strategic reasons where the most important reasons for their previous acquisition. It is therefore 
an important factor to consider when analyzing these types of decisions. The importance of the strategic 
intent is further highlighted by Pablo's (1994) study, and she states:“Strategic intent has at its core the 
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recognition of potential sources of synergy deriving from the interdependencies between the value-
chains of the two organizations” (Pablo 1994). 
 
One of the factors that make the subject of acquisitions more complex is that no two acquisitions are alike 
and have very different needs for integration and coordination in order to reach the synergetic goals intended 
when the decision was taken. These goals could be regarded the strategic motives for the acquisition, and 
there are few different definitions of these goals, of which primarily Hubbard’s (2001) is discussed in the 
theoretical framework.  
 
How mergers and acquisitions are used and their frequency varies between different industries, as the needs 
and specific challenges a firm will face vary between different industries, and firms acting in different 
industries will face different challenges. As Puranam et al. (2009) notes concerning technological firms it 
also affects the decisions taken in when acquiring another firm as to how deep integration will be taken. It is 
therefore imperative to understand the industry one seeks to analyze, what special characteristics governs 
that specific industry. 
 
Puranam et al. (2009) argues that in the case of technological acquisitions the necessary amount of 
coordination between an acquired and an acquiring company is significantly less when the acquiring 
company is manufacturing a standalone product than a component product. They also state that little research 
has been performed concerning the relationship between interdependence and integration, especially when it 
may be managed without integration (Puranam et al. 2009). Furthermore, they mention that too much 
structural integration actually may be harmful to the innovative process, as the firm loses its autonomy. 
Graebner also argues that integration may lead to the destruction of the acquired firm's knowledge-base 
(Graebner 2004). With these strong arguments, one can conclude that it is imperative to consider a firm's 
need of post-merger integration in combination with the core characteristics of its industry in order to find 
the proper degree of integration. 
 
One such industry in which the technological facets have a large impact is the MedTech industry, a broad 
industry that manufactures products used in, for example, x-ray scans, pacemakers, and dialysis (Swedish 
MedTech 2012). Swedish MedTech defines the product range of the industry as “basically all products with 
medicinal connection except medicine” (Swedish MedTech 2012). The industry is highly technology-
dependent and is distinguished by its use of acquisitions in both extent and manner, and some business 
studies consider this as a sign of consolidation within the industry (E&Y 2010). It is therefore an interesting 
industry to dissect within this subject, and study deeper in a smaller context, that is on the corporate level. 
 
One Multinational Corporation (MNC) within this area is Getinge Group AB, a Swedish-based Med Tech 
firm founded in 1904. Today, the company employs more than 12 000 people in 37 countries and has 
partaken in 33 acquisitions between 1990 and 2009 (see Appendix II; Getinge Annual Report 2010). 
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Getinge’s products cover patient handling, sterilization, disinfection, medical systems, surgical systems, 
autoclaves, and surgical equipment, divided into the three business areas Infection Control (Getinge IC), 
Medical Systems and Extended Care, of which the latter two where created after the acquisitions of Arjo and 
Maquet (table 4.1; Getinge AB 2012). 
 
Unlike the automotive industry previously touched on, the MedTech industry is not consolidated nor 
characterized by huge MNC’s. Rather, there exist a lot of smaller firms providing products in different areas. 
One such firm is the French firm La Calhène Group. La Calhène manufactures isolators for a variety of uses, 
one being the application of their products by, for example, pharmacists (La Calhène 2012). Their products 
have been developed from their original nuclear-application of the 1960s to the three areas Health Care, 
Food & Beverages and Nuclear (Getinge La Calhène 2012a). In 2005, the firm had operations in France, UK 
and USA with global distribution and employed 280 people (Getinge AB 2005). This was the same year that 
the firm was acquired by the global MNC Getinge and to be integrated into the business area Getinge IC. 
 
While there has been a lot of research done on the pre-acquisition and post-acquisition phases, there is still a 
lack, to the author’s knowledge, of studies focused on the integration-process that keep the pre-acquisition 
motives under consideration. There exist studies on the cultural aspects of the post-acquisition process 
(Huang & Wang 2010; Fralicx & Bolster 1997). The studies performed on the post-merger integration mostly 
focus on the consequences of certain degrees of integration, and rarely consider the causes of these 
consequences, or the underlying reasons that has led to the decisions taken.  
 
1.1.1 Why La Calhène and Getinge? 
The choice of the acquisition of La Calhène by Getinge Getinge IC was taken, as this type of acquisition is 
fairly common when compared to Getinge Group AB's previous acquisitions (consult Appendix II for further 
information), in which they have acquired firms active within the same type of business area, but with a very 
different, highly specialized product that has not previously been a part of Getinge's product portfolio. 
Getinge Group AB is a large Swedish multinational firm that has demonstrated both organic growth and 
growth through acquisitions. The resulting integration has, for those reasons, been limited, as will be more 
thoroughly discussed and analyzed in chapters 4 and 5. While Getinge has partaken in acquisitions within 
their existing product portfolio as well, these acquisitions have a pattern of allowing Getinge to enter a new 
geographic area. There are, of course, acquisitions that stand out, such as the acquisition of Huntleigh, which 
was merged into the previously acquired Arjo to form the foundation for the Extended Care business area.  
 
1.1.2 Definitions of Capabilities and Integration 
As the terms capabilities and integration will be used to a great extent in the following dissertation, the 
definitions of these terms needs to be addressed. For the rest of the thesis, Integration will be used to imply 
one of two meanings; 1) Structural Integration – that is the combination of two organizational units into one 
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unit following an acquisition; or 2) Informal Integration – that is the creation of common ground– or culture 
– that does not involve the combination of organizational units, but rather an informal means towards 
creating coordination and integration (Puranam et al. 2009). My approach of Informal Integration is a wider 
approach than Puranam et al.'s approach to common ground, which is more dependent on the pre-existing 
common ground between the two firms prior to acquisition, while my approach allows for it as – to some 
extent – exchangeable with structural integration post-acquisition. The emphasis on this dissertation will be 
on structural integration. The term Capabilities will henceforth be referred to as the value-creating activities 
of the firm, such as sales- and service-personnel, research and development functions, manufacturing sites, 
management team, and other similar activities.  
 
1.2 Problem and Focus 
There have been many studies researching the pre-acquisition and post-acquisition processes of an 
acquisition, but, to the author's knowledge, not much has been done in the realm of analyzing the integration 
of the value chain or implementation of the acquisition processes tied to the differing modes of structural and 
informal integration and why different models are chosen. This study will focus on those two areas and their 
importance for a successful acquisition. This will be done through a case study of an acquisition made by 
Getinge, delving into the conditions and implementations of that particular acquisition. 
 
1.3 Purpose  
The purpose of this research is to study an acquisition made by a large multinational firm and analyze the 
degrees of integration chosen, why the firm chooses those degrees of integration, and how the nature of the 
industry impacts on these decisions. 
 
1.3.1 Research Questions 
The research problem will be boiled down in to the following areas:  
 How does the MedTech industry affect the acquisition in the case of Getinge AB and La Calhène; 
 What capabilities of La Calhène are integrated in to Getinge AB, and why; 
 How does Getinge AB integrate La Calhène? 
 
1.4 Delimitation 
This dissertation focuses on acquisition made by Getinge AB, with a special focus on its Getinge IC business 
area. This study will also focus on the acquisition of the French corporation La Calhène Group. The choice to 
focus on one acquisition, rather than a broader study of Getinge AB's acquisitions was taken by reasoning 
that doing so would provide a more comprehensive view of the situation of the particular acquisition and 
therefore be able to draw stronger conclusions about and from the specific situation. The choice of the 
business area Getinge IC was taken because Getinge IC, unlike the two other business areas of Getinge, was 
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not formed around major acquisitions, but has stronger ties to Getinge AB's origin. The choice of La Calhène 
was reached as it is a rather recent acquisition undertaken by Getinge IC and is quite substantial in size, 
while enough time has passed in order for certain conclusions to be drawn concerning the successes and 
complications of the specific acquisition situation. The case study will also be limited to study the situation 
primarily from a managerial perspective. There are certain other limitations as well: 
 
Firstly, the decision to only interview the COO of Getinge IC, Peter Palmqvist, and not the managing 
director of La Calhène or the head of the Life Science division, as well as the fact that acquisitions are a 
strategically sensitive subject may skew the data. The author has attempted to compensate for this by 
providing data from other contemporary sources, such as corporate websites, annual reports and scientific 
articles. Secondly, the personal relationship between Mr. Palmqvist and the author may, in spite of the 
objective approach of both participants, also affect the trustworthiness of the study. The author has worked to 
compensate for such possible effects of the study through the usage of other sources on as many levels of 
analysis as possible. 
 
Thirdly, the study has an overall focus towards the structural integration levels and underlying decisions 
rather than cultural or financial aspects, much due to the previously mentioned study by Huang & Wang 
(2010) that handles the cultural matters of Getinge AB's acquisitions and its process. The study also focuses 
on the integration levels of a firm that was not deeply integrated into the acquiring firm that still retained a 
lot of its autonomy. This fact means that the case-study disregards from some of the potential problems that 
may arise when integrating a firm structurally deeper into the acquiring firm. Finally, the limitations 
described above, combined with the fact the study is a single case-study of a single acquisition, makes it 
difficult to generalize conclusions. In order to do that, the study would have to have a broader perspective, 
either covering a greater amount of different acquisitions within the MedTech industry, and therefore 
generalize the findings to all acquisitions within the industry. Another approach would be to include 
acquisitions form a greater amount of industries, therefore being able to generalize the findings to all 
acquisitions. 
 
1.5 Disposition 
Theoretical Framework – In this section the theoretical basis of the thesis is discussed. In order to understand 
the impact of the industry, the Porter’s model of the five competitive forces is utilized. This is followed by 
Puranam et al.’s model on integration, coordination and interdependence in order to properly what manner of 
coordination and integration has been utilized in order to understand the decisions taken and what type of 
integration observed. This is then boiled down to a discussion on structural and informal integration based on 
the motives and degrees of structural integration required using the theory of Hubbard. The chapter is 
concluded with the presentation of the applications used in the analysis. 
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Methodology – In this section the methods used in the research process are described along with definitions 
of reliability and validity, and how they apply in this specific thesis. 
 
Empirical Findings – In this section the empirical findings are presented, starting with a description of the 
MedTech industry, followed by an in-depth description of Getinge AB and La Calhène. The chapter is 
concluded by describing the integration of La Calhène into Getinge AB. 
 
Analysis – In this section the empirical findings will be analyzed using the theoretical framework previously 
described. Initially, the industry is analyzed in relation to the five forces model, and is followed by an 
analysis of structural and informal integration. The chapter continues to analyze the specific acquisition in 
relation to the previous acquisitions by Getinge AB and is concluded by analyzing the impact of industry on 
the acquisitions decisions. 
 
Conclusions – In this section will be presented the answers to the aforementioned research questions within 
the basis of this study, as well as recommendations for further study. 
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2. THEORETICAL FRAMEWORK 
 
This chapter presents a brief summary of the various theories  
used when conducting the analysis, starting by introducing  
Porter's model of the five industrial forces of , after which the  
model of Puranam et al. is introduced, showcasing the different 
ways in which a firm may be integrated. Following this is a 
description of Hubbard's model of the relationship between 
between motives behind an acquisition and degree of  
integration. This is followed by a description of Getinge AB's 
approach to cultural management as an explanation of 
informal integration. The chapter is concluded by a  
presentation of the models used for analyzing the case. 
 
2.1 The Industry and Its Implications 
In order to properly understand the underlying trends and how they affect the choices a firm makes in its 
acquisitions decisions and to relate this case-study to a larger perspective, the characteristics of the industry 
must be addressed. One of the most famous ways to analyze an industry was presented by Michael Porter in 
1979, namely the model of the five competitive forces. His study and theoretical framework has since 
become very influential and is one of the household names of business-studies. There have been previous 
studies on this model, its implications and its relevance. One such study is that of Ormanidhi and Stringa 
(2008), comparing it to the Structure-Conduct-Performance model, concluding that Porter is supported above 
that theory. Its long-lasting popularity has certainly made it a well-known and accepted model. The forces of 
his theory are presented briefly in the following section. 
 
2.1.1 Porter's Five Forces 
Figure 2.1 Porter's Five Forces Source: Porter (1979)  
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Threat of new entrants is a part of Porter's (1979) model that describes the level of the threat that new 
competitors might enter the industry analyzed. This force factors in such determinant as barriers of entry, 
sunk costs and industry profitability. An industry with high barriers of entry and high sunk costs is less likely 
to have a high threat of new entrants, for example. This force also covers the fact that in an industry with 
highly specialized technology, the threat of new entrants is decreased. 
 
Threat of substitutes is a part of Porter's (1979) model that describes the threat of customers exchanging 
(substituting) one product for another within the industry. It covers the ease with which this is done, the costs 
of doing so, and the price elasticity of the customers. An industry in which it is easy and cheap to switch 
provider is more likely to have a high threat of substitutes. As the product gets more specialized and unique, 
the threat of substitutes decreases. 
 
Bargaining power of customers is a part of Porter's (1979) five forces model that describes the power of a 
customer relative the supplier and that impact on the industry. It covers the information available to the 
buyer, buyer price sensitivity, the dependence on existing distribution channels and existence of substitutes. 
An industry in which the buyer is highly price sensitive and has a low dependence on existing distribution 
channels is more likely to have a high bargaining power of customers. 
 
Bargaining power of suppliers is a part of Porter's (1979) five forces model that describes the power of a 
supplier relative the buyer and its impact on the industry. It covers the strength of distribution channels, 
supplier competition, supplier concentration contra buyer concentration etc. An industry with strong 
distribution channels and a high concentration of suppliers is more likely to have a high bargaining power of 
suppliers. 
 
Intensity of rivalry is a part of Porter's (1979) five forces model that describes the rivalry within the industry, 
and what impacts that has on the industry. Factors such as innovation and high fixed costs also factor in. An 
industry with high intensity of rivalry is characterized by a large number of firms, low switching costs and 
high fixed costs.  
 
2.2 Post-Acquisition Integration 
In order to understand the acquisition-integration process, there is need to formulate some form of model that 
can explain the underlying factors for the different modes of integration, and why integration is needed. One 
such model is the theoretical formula of Puranam et al. (2009) which uses the factors of structural 
integration, common ground, coordination capacity, need for coordination and interdependence depicted in 
figure 2.2. These factors are, as will be presented, affected by the nature of the industry, especially its 
technological nature. 
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Puranam et al. (2009) argue that there are instances in which structural integration post-merger and post-
acquisition is, in fact, unnecessary. Their paper is primarily concerned with structural integration, which they 
define as the “combination of formerly distinct organizational units into the same organizational unit 
following an acquisition” (Puranam et al. 2009). They continue to state that the value of an acquisition is 
created by linking the capabilities of the acquiring firm with the acquired firm, but that the extent to which 
this is required vary greatly (Puranam et al. 2009). They also distinguishes between structural integration and 
separation, where the latter is defined as activities in both firm (the acquirer and the acquired) remain distinct 
organizationally all though they are under the same ownership (Puranam et al. 2009). They also argue that 
structural integration may have the consequence of disrupting the innovative capabilities of a firm, which 
may very well be driving competitive capabilities in firms working with technology (Puranam et al. 2009). 
 
Furthermore, the interdependence of the two firms determines how value will be created after the acquisition, 
but not how much value will be created (Puranam et al. 2009).  
 
The authors also argue that in technology acquisitions of stand-alone products require less interdependence 
than the acquisition of firms manufacturing component products of their existing product portfolio (Puranam 
et al. 2009). In contrast, they argue that informal coordination created by common ground, that is shared 
knowledge which the actors knows are shared, might actually make more formal coordination such as 
structural integration unnecessary (Puranam et al. 2009). Supporting this is the study by Amiryany et al. 
(2012) shows that integrating and transferring the acquired knowledge-base is one of the main objectives of 
knowledge acquisitions – which is one form of these types of acquisitions. They also found that social 
interaction is imperative for sharing the specific knowledge that the acquired firm has, and that this is the 
decisive factor for acquisitions undertaken in order to innovate (Amiryany et al. 2012). Both studies point 
towards a creation of common ground between the acquirer and the acquired is very important for realizing 
the potential for the acquisition. Much like Puranam et al. (2009), Amiryany et al. (2012) argue that 
coordinating and integrating an acquired firm through the usage of direction and routine would imply a loss 
of knowledge, as not all knowledge may be converted into the new firm, implying structural integration 
through their definition of direction (the conversion of tacit knowledge to explicit knowledge).  
 
Further, the definition of coordination capacity as a concept that aims towards creating “sufficient knowledge 
among interacting individuals such that they can adequately anticipate each others actions, and adjust their 
own accordingly” that is acquired through a combination of structural integration and informal integration 
(Puranam et al. 2009). Coordination capacity may therefore be considered as the resulting cultural interaction 
created through the modes of informal and structural integration, where structural integration is a direct 
cultural interaction through the integration of capabilities into the acquiring firm, while informal integration 
is the usage of less direct modes of integration. 
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Culture is defined by Hofstede (1997) as “the collective programming of the mind distinguishing the 
members of one group or category of people from others”, that is a form of common ground between 
different people. The conveying of culture can therefore imply the informal integration that occurs between 
the acquiring and the acquired firm in order to create a common ground of shared knowledge which is 
known to be shared. Informal integration may therefore be regarded as the means of sharing culture and 
knowledge outside the structural integration processes. Puranam et al. does, however, comment that informal 
integration through common ground is not perfectly interchangeable with structural integration. 
 
Interdependence in this formula is the degree to which the acquirer and the acquired are dependent on one 
another. Puranam et al. (2009) argues that technology acquisitions concerning component technologies are 
more prone to a high interdependence, while stand-alone products generally have a smaller degree of 
interdependence. They also found that a high interdependence is linked with a higher structural integration in 
component-acquisitions than in stand-alone acquisitions (Puranam et al. 2009). This is not very surprising, 
seeing as this shows the differences between the vertical expansion and market entry motives for an 
acquisition (further explained in section 2.2.1.2). Interdependence is also linked to the need for coordination 
between the acquirer and the acquired (Puranam et al. 2009), but is not the only deciding factor for it, as a 
technology acquisition with aims to acquire knowledge still needs higher modes of coordination than their 
original interdependence (Amiryany et al. 2012). 
 
Puranam et al. conclude by stating that the effect of loss of autonomy is outweighed by the coordination in 
instances in which the interdependency is high, which is generally the case concerning component 
technology acquisitions (Puranam et al. 2009). When acquiring a stand-alone product firm the 
interdependence is generally low, this also stands true for the gains of structural integration (Puranam et al. 
2009). 
 
What their study shows is an argument for instances in which structural integration is not necessary, and 
when it is, as well as providing a model presenting their argument. Their reasoning has a strong base for 
analysis of acquisitions made in which the acquisition of technology play a large role, and adeptly shows 
when more informal ways of integration are more suitable than formal ones, putting interdependence and 
needs of coordination against the coordination capacity, made up of structural integration and common 
ground. The model also shows instances in which structural integration may still be observed, although the 
major form of coordination capacity is through informal integration as well as the link between 
interdependence and need of coordination. Their model also puts emphasis on the connection between the 
need for coordination and coordination capacity, of which the interdependence, informal and structural 
integration are factors. 
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  Figure 2.2 Formula of Post-Merger Integration Source: Puranam et al (2009) 
 
In order to understand and further develop on this model, the factors informal and structural integration will 
be further examined. 
 
2.2.1 Structural Integration 
Previous research has concluded that the reasons for making the acquisition-decision have great implications 
to the levels of integration that would be expected from the specific acquisition (Hubbard 2001). 
Acquisitions are, as previously mentioned, a very complex subject, but is a very widespread phenomenon 
and continues to be one of the most common strategic moves (Lohrum 1999). There are a number of 
different degrees of structural integration distinguished, and all though every implementation of an 
acquisition is different, most fall under the following varying levels of integration;  total autonomy, 
restructuring followed by financial controls, functional integration, and total integration (Hubbard 2001). 
Knowing the strategic motives behind the acquisition also helps anticipate the expected level of structural 
integration, and previous research has shown that there are six primary strategic reasons for an acquisition; 
market penetration, vertical expansion, financial synergies, market entry, asset potential/synergy, and 
economies of scale (Hubbard 2001; Spratt & Feldman 1999). These may also be paralleled to the World 
Investment Report's classification diversification of acquisitions, namely horizontal, vertical and 
conglomerate (World Investment Report 2000). The structural integration described by Hubbard is a good 
representation of how a firm structurally integrates their physical capabilities based on the underlying 
motivations for an acquisition, which ties it closely to the Structural Integration of Puranam et al.'s (2009) 
formula. 
 
2.2.1.1 Degrees of Integration 
Total autonomy is a form of acquisition in which there is no structural integration of the acquired firm into 
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the acquiring firm, and only interacts with the acquirer through financial controls (Hubbard 2001). Hubbard 
(2001) explains that the subject of the acquisition is left to operate separate from the acquiring firm's 
capabilities much in the same way as it did prior to the acquisition. This form of acquisition is generally 
made to secure certain key-components, geographical access or to acquire financial synergies (Hubbard 
2001). This type of acquisition, though it may appear to be a rather simple process, still require the same 
preliminary analysis as any other acquisition, but will rather yield the result that integration should not be 
undertaken (Gendron 2004). This analysis is important to make, as it must ascertain that there are no 
unsupported commitments made (Gendron 2004). 
 
Restructuring followed by financial controls is a form of acquisitions in which some functions of the 
acquired firm is in some form modified by the acquirer, and then left to stand-alone operations, controlled 
only by financial controls similarly to total autonomy (Hubbard 2001). Examples of modifications could be 
an exchange of management, or introduction of new technology (Hubbard 2001). Similarly to total 
autonomy, financial synergies may also be acquired through this degree of integration. 
 
Functional integration implies the structural integration of certain key-functions or departments and is a 
form of acquisition performed strictly to acquire economies of scale, and therefore rationalize the two firms 
(Hubbard 2001). Departments or functions that could be centralized in this manner are, for example, 
marketing, head-offices and marketing, that is, to acquirer either economies or business of scale (Larsson 
1985; Gendron 2004) further discussed in 2.2.2. 
 
Full integration which, as the name implies means that the acquired firm is completely structurally 
integrated into the acquiring firm with the intentions of acquiring great economies of scale and acquire other 
financial and operational synergies of a fully merged entity (Hubbard 2001). 
 
These different types of structural integration also shows the relation of power between the two entities post-
acquisition, something that Pablo (1994) says is crucial to take under consideration.  
 
2.2.1.2 Strategic Reasons for Acquisition 
Market penetration is a form of acquisition taken with the intent of acquiring stronger market power in order 
to acquire an edge to its market/customer base (Hubbard 2001). This may be paralleled to the horizontal 
acquisition, in which firms are acquired that share products and markets with the acquiring firm (World 
Investment Report 2000). Unlike horizontal acquisition, however, this approach is not quite as broad as that 
approach, and is somewhat ambiguous, as it shares characteristics of the horizontal acquisitions strategy 
along with the economies of scale strategy. The reasons for Hubbard's decision to divide this strategy into 
these two different motives is probably in order to relate the different types of acquisition motives to a 
specific level of integration expected, as will be discussed further in 2.2.3.  
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Vertical expansion is a form of acquisition that is taken in an attempt to acquire control of components or 
resources critical to their production, or certain means of distribution or similar reasons (Hubbard 2001). 
This type of acquisitions are not bound by any specific path in the value-chain, but could be either both a 
producer acquiring a supplier or distributor, or even a potential supplier or distributor. These different types 
of acquisitions are either referred to as forward or backward acquisitions, where a forward acquisition is 
exemplified by a producer acquiring a supplier, and a backward as a producer acquiring a supplier (World 
Investment Report 2000).  
 
Financial synergies is a form of acquisition that is taken solely in order to acquire financial synergies 
between the acquirer and the acquired, such as earnings enhancements, tax breaks or accounting 
modifications (Hubbard 2001). Leland (2007) however concludes that potential financial synergies are not a 
motive enough for either a merger or an acquisition, but that it may play an important role in certain cases. 
Gendron, however, pointed out that there are still compelling reasons for undertaking an acquisition for 
financial synergies, such as diversity of the business-cycle, or for scale of business (Gendron 2004). He 
further explains that scale of business means that the acquirer seeks to eliminate overhead costs, such as 
marketing, sales or similar administrative costs. Unlike Gendron, Hubbard relates scale of business more 
closely to economies of scale discussed further down, which may yield more strength to Leland's argument 
in this case. 
 
Market entry is a form of acquisition that is taken in order to enter new markets in either new geographic 
regions, or new industries (Hubbard 2001).  Gendron (2004) differentiates between two different types of 
product-related acquisitions into product line extension and product line expansion, of which the previous is 
an acquisition of a firm producing a complementary line of products, while the other offers an entirely 
different line of products. The former may be used in this context to either to acquire a new customer-base in 
a region they already are present in, or to enter a new geographic region. The latter could be used to enter 
new industries, but was likely not suited for full integration, but rather undertaken in order to secure future 
products form that product-line. 
 
Asset potential/synergy is a form of acquisition that is taken because the acquirer's management believes they 
can run the operation of the acquired firm more efficiently in some manner than the firm's current 
management (Hubbard 2001). This type of acquisition could be motivated by acquiring key personnel form 
the acquired firm with vital technological competencies, or by a desire to gain access to the research and 
development process (Gendron 2004).  
 
Economies of scale is probably one of the first acquisition motives that people think of, much due to the fact 
that the media coverage of those kinds of acquisitions are usually more extensive, such as the case of Ford 
and Volvo (Olsson 1999). This type of acquisition is characterized by intent to either acquire economies of 
scale in the production of products by combined operating sites or scale of business by integrating back-
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
20 
 
office functions such as administration (Hubbard 2001). Hubbard also links what Gendron calls diversity of 
the business-cycle to this type of acquisition. This makes Hubbard's view on the economies of scale-motive a 
motive to rationalize costs, which therefore differentiates it from her view on market penetration, which 
instead becomes limited to other ways of acquiring power over customers than price and cost-reductions. 
 
2.2.2 The Expected Level of Structural Integration When Related to Strategic 
Reasons For Acquisition 
As previously mentioned, the strategic motivations for an acquisition will impact the desired and expected 
level of integration between the two firms (Hubbard 2001), and, as Gendron (2004) states; the “strategic 
intent of the acquisition will determine the type and extent of planning and review required”. If the strategic 
intent is to acquire economies of scale, the acquirer must plan for the structural integration of the specific 
functions with which the acquirer wishes to acquire economies of scale through.  
 
Nancy Hubbard (2001) has devised a chart (see figure 2.3) using both the diversified motives for acquisitions 
that were described in 2.2.1.2 and the degrees of structural integration described in 2.2.1.1 to form a chart 
that plots shows the required and/or expected levels of structural integration that such a motive would 
warrant. She also distinguishes between “likely”, “probable” and “unlikely” degrees of structural integration 
for the specific motives. What is important to note is that the chart also allows for several reasons for 
acquisitions to be combined in order to find the most probable level of structural integration required and/or 
expected. For example, the expected level of structural integration for an acquisition undertaken with the 
motive of vertical integration would likely be changed with controls (restructuring followed by financial 
controls), but might also have full autonomy or functional integration. If the reasons for acquiring are 
vertical integration and market entry, the functional integration of the firm becomes more unlikely, while the 
choices of total autonomy and change with controls are still viable.  
 
 
 Financial 
Controls 
Change with 
Controls 
Functional 
Integration 
Total Integration 
Financial 
Synergies 
Likely Possible Unlikely Unlikely 
Market Entry 
 
Likely Possible Possible Unlikely 
Vertical 
Integration 
Possible Likely Possible Unlikely 
Asset Potential 
 
Possible Likely Possible Unlikely 
Market 
Penetration 
Possible Possible Likely Possible 
Economies of 
Scale 
Unlikely Unlikely Possible Likely 
Figure 2.3 Expected/Required Level of Integration Source: Nancy Hubbard (2001) 
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2.2.3 Getinge AB's Approach to Acquisitions, Internationalization and Informal 
Integration 
Huang and Wang (2010) conducted a study on Getinge AB concerning their approach to internationalization 
through acquisitions, as well as the pre-acquisition and post-acquisitions processes. Their findings provide 
certain information that is good to understand in the processes of informal integration in the integration of La 
Calhène and how Getinge AB handles both the acquisitions processes on a strategically level, and how they 
implement these strategies. 
 
Huang and Wang (2010) found that Getinge AB uses the distinction between bolt-on acquisitions and 
strategic acquisitions. Bolt-on acquisitions are described as involving corporations that are small in size that 
are acquired only to fuel the strength of the company, while the strategic acquisition was characterized as 
being large in size, involving large sums of money and risk where mistakes are costly and imply serious 
consequences (Huang & Wang 2010). They further link strategic acquisitions to platform acquisitions, and 
bolt-on acquisitions to bolt-on acquisitions, both as defined by Nolop (2007), where the latter fits well into 
the existing business, whereas the other involves higher risks and rewards.  
 
These acquisitions are generally accompanied by one of two motives: technology acquisitions and 
acquisitions to strengthen market/sales (Huang & Wang 2010). Technological acquisitions-decisions include 
an evaluation of the acquired firm’s product portfolio and its strategic fit into the Getinge AB's current 
product portfolio. Technology acquisitions may be related to the market entry strategy of the structural 
integration model, as well as the technology acquisitions covered by the theories of Puranam et al. (2009) 
and the distinction of knowledge acquisitions of Amiryany et al. (2012). The motive of acquisitions to 
strengthen market/sales may be linked to the motive of market penetration and economies of scale, which 
leaves the motive of asset synergy/potential uncovered. Reasonably, the motive could be linked to 
technology acquisitions, especially in the case of asset synergy. 
 
The cultural management post-acquisition is generally dealt with through frequent contact on the managerial 
levels that is between the managing directors, as well as with human resources, as it is the leaders that set the 
basis for culture that will be adopted into the firm (Huang & Wang 2010). These functions are emphasized in 
figure 2.4, which shows all the levels in which cultural exchange between Getinge AB and the acquired firm 
is undertaken.  
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Getinge AB  The Acquired Company 
Managing Director              Managing Director 
Human Resource              Human Resource 
Administration              Administration 
Sales & Marketing              Sales & Marketing 
Finance              Finance 
Manufacturing              Manufacturing 
Figure 2.4 Cultural Exchange Within Getinge AB Regarding Post-Acquisition Management  
Source: Huang & Wang 2010 
 
2.3 Conclusion of Theoretical Framework 
Thus far have been discussed the theories of Nancy Hubbard (2001) on the strategic motives behind an 
acquisition and the required level of integration (Figure 2.1), the previous study on Getinge AB and its 
acquisitions (Huang & Wang 2010), the theories on the five forces of an industry, and the necessity of 
integrating firms post-merger (Puranam et al. 2009). The implications of these studies on this thesis is the 
easily utilizable chart that Hubbard (2001) provides, all though the full integration is of little interest for this 
study, neither is the motive of vertical expansion.  
 
The model presented by Porter (2008) is a good tool for analyzing why acquisitions functions the way they 
do in this particular industry and analyze why acquisitions are performed in this way in this particular 
industry. It is, in other words, a good tool for understanding why certain decisions are more common in the 
industry than others, as firms partaking in acquisitions will be affected by the underlying characteristics of 
the industry. The specific integration required and undertaken is explained by a version of the model 
presented by Puranam et al. (2009), depicted in figure 2.6. What differs my interpretation of this model from 
the original model is my interpretations of the different factors affecting the coordination capacity of their 
model. The structural integration factor is explained by Nancy Hubbard's (2001) table depicting what level of 
structural integration is required for certain strategic motives behind the acquisition. The common ground 
factor of Puranam et al.'s (2009) model is exchanged by an informal integration factor, factoring in both 
common ground and post-merger cultural management factors. The need for coordination factor is also less 
strongly tied to the interdependence in my interpretation of the model, factoring in the possibility that certain 
acquisitions are undertaken in order to acquire certain technological innovations (such as Huang and Wang's 
(2010) study shows) or certain knowledge-based capabilities that cannot be integrated through structural 
integration (as the study of Amiryany et al. (2012) implies) as well as the risk of disrupting innovative 
capabilities if structural integration would be undertaken nonetheless  (following the basic intentions of  
Puranam et al. (2009)). The informal integration is not the focus of this dissertation, but is nonetheless 
touched on using the previous study of Huang and Wang (2010) to explain how Getinge AB functions in 
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these matters, and to reflect these with the observed interactions. 
 
Following is both an altered version of the table provided by Hubbard (2001) (figure 2.5) depicting the 
structural integration of my altered Puranam et al (2009) model, having eliminated vertical expansion as a 
possible strategic motive, as it does not relate to the specific case, and total integration, as it can be clearly 
stated that it has not occurred, without overstepping my objective boundaries. Following that is an altered 
version of Puranam et al.'s (2009) model, showcasing the emphasis of this dissertation and the changed 
denominations for the factors.  
 
 
 Financial Controls Change With 
Controls 
Functional Integration 
Financial Synergies Likely Possible   
Market Entry Likely Possible Possible  
Asset Synergy Possible Likely Possible  
Market Penetration Possible Possible Likely  
Economies of Scale   Possible  
Figure 2.5 Structural Integration Dependent On Strategic Motives Adapted from figure 2.3 (Nancy 
Hubbard 2001) 
 
 
 
Figure 2.6 Theoretic Model For Post-Acquisition Integration Adapted from Figure 2.2 by 
Puranam et al. (2009). 
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3. METHODOLOGY 
 
The methodological approach used to conduct a research  
study is influenced by the choice of field and problem to  
analyze. The following chapter presents the methodology used  
in this specific study, that is a qualitative case-study using  
semi-structured interview and official data as collection of data  
and conducted using an interpretive hermeneutic approach. 
 
3.1 Research Approach 
There are two primary research methods, namely qualitative and quantitative methods, that are used to 
acquire data to be analyzed and used for scientific research (Fisher 2007). The quantitative method is 
distinguished by questionnaire surveys and databases, while qualitative is focused on interviews and 
observation. According to Fisher (2007), there is a tendency for linking the two methods to the primary 
research methodologies, namely realist research and the interpretive research. As he claims, both 
methodologies may use both methods of acquiring data, but they generally have different ways of 
approaching the same type of research method (Fisher 2007). The realist research approach “identifies and 
evaluates options for action” and is characterized by structured variables, reductionism, cause and effect, 
and statistical analysis (Fisher 2007). While a realist research approach might use the qualitative method of 
interviews in the same manner as an interpretive research approach might use the quantitative method of 
questionnaires, it is characterized in that it usually uses this type of data collection through a large sample 
and fixed-choice questions (Fisher 2007). The tests of hypothesis and the attempt to find patterns in the 
selected data also characterize this research approach. 
 
The interpretive research approach believes that “understanding provides a context for thinking about action, 
but does not specify it” and is characterized by dialogic structures, participant observation, explores meaning 
and deals with complexity (Fisher 2007). This approach believes that the link between knowledge and action 
is indirect, and that improving understanding does not necessarily lead to the best action, but should help 
reaching a better action (Fisher 2007). An interpretive researchers usually have one of two perspectives to 
choose, either with a concern to meanings and interpretations (phenomenology), creating structures from 
interpretations similarly to a realists creation of structure from variables, or processual perspective 
(hermeneutics), which is “an attempt to generalize about how meaning is developed through human 
interaction” (Fisher 2007). This latter approach puts a lot of emphasis on uncertainty and complexity (Fisher 
2007) as processes are not linear and because political processes plays a role in these issues (Dawson 1994). 
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In view of these definitions, an interpretive qualitative study is chosen, using a hermeneutic perspective. 
 
3.2 Validity and Reliability 
According to Yin (2009) there are four ways through which to judge the quality of research designs; 
construct validity, internal validity, external validity and reliability. Construct validity is concerned with 
“identifying correct operational measures for the concepts being studied” (Yin 2009), and in order to acquire 
this, a researcher needs to be aware of the fact that his/her constructs do not refer to what they claim they do 
(Fisher 2007). Internal validity is judged by its attempts to “establish a causal relationship, whereby certain 
conditions are believed to lead to other conditions, as distinguished from spurious relationships”, and is 
concerned with whether an action is incorrectly believed to lead to an effect, where, in fact, a third factor was 
the cause of the effect, and with inferences, that is points where an event cannot be observed (Yin 2009). 
External validity is judged by its attempt at “defining the domain to which a study's findings can be 
generalized” (Yin 2009), and can be conducted either through statistical analysis or theoretical analysis, in 
which the findings are generalized in the context of the theory tested and should include a “detailed enough 
description of the research material to allow the reader to make their own judgments about transferability” 
(Fisher 2007; Yin 2009). Reliability is concerned with whether it is possible to replicate the study and 
achieve similar results, in a case study this is done through replicating the same case (Yin 2009). By using a 
large amount of primary and secondary sources and addressing rival explanations for the causes and effects 
of the observed case the author has strived to achieve both reliability and validity in the dissertation. The 
information used was acquired through the semi-structured interview with the chief of operations of  Getinge 
IC, complemented with a large variety of secondary sources. 
 
3.3 Case Study 
According to Fisher (2007) a case-study is a preferable way of conducting research when the researcher 
seeks to acquire “an in-depth understanding of particular situations” as they provide the researcher with a 
holistic account, covering all the factors of the case which the researcher wishes to study. Above all, a case 
study helps the researcher focus on the interrelationships between all the factors that affect the problem 
elected (Fisher 2007) as Yin (1994) notes that it is not always apparent which factors of the problem are a 
part of the phenomena, and what factors are part of the context. A case-study is characterized by its narrow 
perspective and approach, using many variables on a single site in real-life contexts (Fisher 2007). Yin 
(2009) notes that another distinguishing characteristic of a case-study is the usage of questions such as 
“how” and “why”. 
 
As the aim of this particular study is to acquire in-depth knowledge in one acquisition performed by a 
multinational and the research questions are all characterized by questions as “how” and “why”  a case-study 
is chosen as the most fitting way to perform this study. 
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3.3.1 Case Selection 
According to Yin (2009) there are five primary types of cases that provide sufficient reasons for conducting a 
single case-study, namely; critical case, unique case, representative/typical case, revelatory case, and 
longitudinal case. A critical case is used to test a well-formulated theory and may either confirm, challenge 
or disprove the theory, while a unique case represent an instance where a very rare phenomenon is studied 
due to its rarity (Yin 2009). The typical case is chosen, as it is a good representation of the natural state, 
while a revelatory case is chosen based on the fact that the phenomenon has previously been available for 
study (Yin 2009). Finally, a longitudinal case is a case in which the same case is studied at two different 
points in time (Yin 2009). 
 
The case selected was chosen by using the typical case approach, as it is a good representation of this 
specific type of acquisition within this industry. 
 
3.3.2 Data Collection 
Data collection was initially undertaken by using official sources, such as press-releases, annual reports and 
information from the corporate websites along with previous research conducted on Getinge AB (in the form 
of the study of Huang & Wang) and industry studies (such as the study by Ernst & Young or L.E.K. 
Consulting) was utilized in order to acquire a good overview of the companies, the industry and the specific 
case. Using these sources, the author acquired a lot of qualitative and quantitative data which was later used 
in the empirical findings used in the study.  The author then used this information in relation to the 
information acquired to evaluate what further information was required in order to answer the research 
questions and what was needed to be doubled-checked through other sources in order to acquire validity in 
the research (Yin 2009). Following this research was the construction of the interview guide (Appendix I) 
that was to be used for the semi-structured interview, constructed to offer freedom to the interview-subject 
through open-ended questions (Fisher 2007) concerning the acquisitions process of Getinge AB, the 
acquisition of La Calhène and cultural issues concerning both acquisitions in general and La Calhène.  
 
In the collection of data from sources such as industry studies, corporate websites and annual reports, the 
author elected to make precedence for corporate websites and annual reports as a source of primary 
information. However, in order to more effectively acquire a broad scope of the nature and state of the 
industry of interest industry studies by renown consulting corporations such as Ernst & Young are a reliable 
source of information providing this scope. The master dissertations of Huang & Wang (2010) and Sofia 
Fahlén (2007) are also great sources for information, providing more detailed analysis of the particular 
corporation (as in the case of Huang and Wang (2010)) or the nature of the industry (as in the case of Fahlén 
(2007)).  
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The interview questions was then written in order to either confirm or contradict what theory and empirical 
findings had already found, and to fill the holes that the empiric had left. The open-ended nature of the 
questions lead to several findings that was not covered in neither theory nor previous empirics, after which 
further theoretical framework was developed in order to understand and analyze the information acquired. In 
order to increase the trustworthiness of those findings I also sought for and acquired additional empiric 
evidence in order to support or contradict the findings from the interview, as a strengthened validity and 
reliability was desired.  
 
The interview-subject chosen was positioned at a key-position of the acquiring firm, being able to offer 
unique insights into the integration of the acquired firm. The empirical data was later also reviewed by the 
interview-subject, in order to avoid misunderstanding and leakage of sensitive information. 
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4. EMPIRICAL FINDINGS 
 
This section presents the empirical findings in the research of  
the problem on the chosen subjects. The chapter initially  
describes the nature of the MedTech industry, and then follows 
by outlining the specific characteristics of Getinge AB, covering 
its multitude of acquisitions. After this, La Calhène is presented 
and the chapter is concluded by covering the empirical findings 
on the integration observed of La Calhène. The findings are 
presented in a layout that is in line with the theoretical  
framework. 
 
4.1 The MedTech Industry 
Mr. Peter Palmqvist (COO of Getinge IC, 30 May 2012), who has experience from the automotive industry, 
divulges on the specific nature of the MedTech industry in which Getinge AB operates. The industry, he 
claims, is marked by its technology, which is advanced and requires considerable education in order to sell it. 
The products need this high-technological nature in order to fulfill its functions. He also says that the 
MedTech industry is very fragmented, marked by a variety of small, specialized firms that are driven by 
entrepreneurship and innovation, but that there also exists a number of larger firms. Innovation is, in fact, 
one of the primary drivers of the industry, and the industry is still growing (Ernst & Young 2011). In Sweden, 
there are three larger firms within this industry, namely Getinge AB, Gambro and Elekta (Bio-Medicine 
2007).Of these, Gambro manufactures supplies for liver and kidney dialyses (Gambro 2011a) while Elekta 
manufactures solutions for treating brain and cancer disorders (Elekta 2012). Both of these firms have used 
acquisitions as a means of growth (Gambro 2011b; Elekta Annual Report 2011).  
 
Mr. Palmqvist’s claims are supported by an industry study performed by Ernst & Young (2012), which 
numbers the amount of players on the MedTech arena to just short of 1'800 in Europe and USA. It also 
emphasizes the importance of innovation and acquisitions for the industry, but also the shift towards 
collaboration and health-outcomes in the sector (Ernst & Young 2012). Rodewald (2011) also support this 
shift, claiming that the “competition in the MedTech space is more about quality than costs”, and 
corporations are prone to manufacturing in high-cost markets, as their competitive advantage stems from a 
well-educated work force.  
 
It is a very complex industry, however, and industry studies imply that the competition that firms active in 
the industry face is not only from other MedTech firms. One such study is one by L.E.K. Consulting, who 
found opportunities and threats between MedTech firms and drug companies within the life science 
department (L.E.K. 2010). Other research mentions the threat Elekta faces regarding their idea of conducting 
brain-surgery through the introduction of high acceleration technology, which lead Elekta to acquire this 
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potential competitor (Fahlén 2007). 
 
While the industry in its own right is constantly evolving due to its reliance on acquisitions, so is the market 
they are facing evolving. The recent health care reform in USA is predicted to alter the market, as the 
hospitals of USA have started to view their suppliers more holistically, opting for single suppliers rather than 
a variety (Ernst & Young 2012). The study of Ernst & Young also predicts that the number of firms in the 
MedTech industry will shrink due to the increased risks for venture capitalists, which combined with their 
description of acquisitions as the only real exit-strategy as a funder, implies an increase in acquisitions and a 
consolidation of the market. 
 
According to the interview with the COO of Getinge AB, this is a trend in the MedTech industry, as it is an 
industry that is still growing and evolving, but there also exists larger firms, such as Gambro and Elekta. In 
spite of this, it is still a fragmented industry in stark contrast to the consolidated automotive industry, which 
is dominated by firms such as Ford, Toyota and Volkswagen. The MedTech industry is also driven by 
innovation and entrepreneurship, which would explain the number of small firms within the industry. 
 
A study by Huang and Wang (2010) highlights one tendency of the MedTech industry, namely that usually 
firms has to compete with several other companies in order to acquire a good candidate for their business-
portfolio. They also found that Getinge AB, as a part of their pre-acquisition process, have been known to 
perform surveys on their current customers in order to find out whether or not a new form of technology 
would be accepted by the market, approaching up to 100 customers for this knowledge (Huang & Wang 
2010). This implies that the competition in the industry is not only in a seller-to-buyer-fashion, but has also 
spilled into a competition on the acquisition-level.  
 
4.2 Getinge AB's Basic Information 
Getinge AB is, in their own words, “a leading provider of products and services for operation rooms, 
intensive-care units, care units, sterilization centers, elderly care and companies and institutions that are 
active in the Life Science area” (Getinge Annual Report 2010), with activities divided in three business 
areas: Extended Care (ARJOHUNTLEIGH), Medical Systems (MAQUET) and Getinge IC (with the three 
customer segments Healthcare, Pharmaceutical/Medical Device and Research) (Getinge AB 2012c). The 
company that would grow to have yearly net sales of roughly 2469 mEUR in 2010 (Getinge Annual Report 
2010, calculated from mSEK) was founded by Olander Larsson in 1904 producing and selling agricultural 
machinery under the name “Getinge Nya Mekaniska Verkstad AB” (Getinge AB 2012b; Getinge Industrier 
Annual Report 2000). In 1932 Getinge AB sold its first sterilizer, a step which the corporation regards as its 
first step towards its current business focus (Getinge Annual Report 2000). Getinge AB was later acquired by 
Electrolux in 1964, which made them part of the large appliance manufacturers international group (Getinge 
Annual Report 2000). The first acquisition Getinge AB partook in was in 1973, when Disinfection Company 
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Växjö Rostfritt and autoclave manufacturer CTC was acquired (Getinge AB 2012b). After partaking in a 
number of acquisitions, Rune Andersson and Carl Bennet would then acquire the company from Electrolux 
in 1989 (Getinge AB 2012b). Following this change of ownership, Getinge AB would then proceed to 
acquire a number of firms, most importantly Arjo in 1995 and Maquet in 2000 (Getinge AB 2012b) which 
would later form the basis for the business areas extended care and medical system respectively. Getinge AB 
would later also acquire Huntleigh in 2007 to broaden the product offering of extended care, the largest 
acquisition the firm has undertaken (Getinge AB 2012b). A detailed entry of Getinge AB’s previous 
acquisitions is listed in Appendix II. 
 
   Picture 4.1 Getinge AB Source: Getinge AB Corporate Website 
 
 
4.2.1 Getinge Infection Control 
Getinge IC is the business area with the strongest connections to the origin of Getinge AB, as their products 
involves products used for sterilization and disinfection, and was not formed based on larger acquisitions, but 
has been developed through both acquisitions and organic growth (Getinge AB 2012b). Getinge IC also 
claims to excel in the integration of the technology of their product offer in order to provide complete 
solutions to their client’s needs (Getinge AB 2012a).  
 
From the interview with Mr. Palmqvist, several enlightening insights were acquired. Getinge IC is divided 
into two business divisions, namely Healthcare and Life Science, where the products of Healthcare are more 
standardized than those of Life Science, but are otherwise function very similarly. The Life Science division 
operates closely to the customer in order to ascertain its needs, and uses the competencies and personnel of 
its various corporations to develop a complete solution to the client's needs. Sometimes that requires the 
creation of entirely new technology, while other times the division needs to fit the current product offer into a 
single cohesive offer. The Health Care division has a more standardized offer, in comparison to the Life 
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Science division, but also offers complete solutions through a consultative approach. 
 
4.3 La Cahene's Basic Information 
The 40-year old La Calhène Group is a subdivision of Getinge AB's business area Infection Control that was 
acquired in 2005 from its previous French owners. The group is based in Vendôme and had reported, at the 
end of their last independent financial year (2005), sales of 40 million Euros with about 280 employees with 
activities in UK, France and USA (Getinge AB 2005) with production in Vendôme, Rush City and just 
outside Paris. The La Calhène Group offers products for manipulation of nuclear waste transfer and 
transportation, isolators for protection of food-products, and healthcare products, such as isolators, life 
sciences and products used for testing sterility (Getinge La Calhène 2012a). The Group has a 40-year old 
experience of the nuclear industry, which is their original business area, experience which they implement in 
their other, younger areas of business (Getinge La Calhène 2012b). As Mr. Palmqvist puts it: “Their product 
portfolio comes from a background of how to isolate different environments from one another and how to 
transport them, regardless of whether it is an aggressive environment you want to protect the environment 
from, or a sterile environment that you want to protect from the environment.” (translated) 
 
Similarly to Getinge AB, The La Calhène Group caters the needs of large pharmaceutical companies, but 
also have other customer segments, such as research laboratories, nuclear fuel waste processing plants, and 
the food-processing industry (Getinge La Calhène 2012a; Getinge AB 2005). The group has strong 
connections to their main-plant in Vendôme, in which a majority of their employees are positioned, tasked 
with both production, production development, and sales and marketing.  
 
Upon being acquired in 2005 by Getinge AB, Getinge AB stated in their press release of the acquisition that 
the expected integration would primarily include the marketing organization of Getinge IC and expected a 
strong growth in volumes. They also wanted to integrate the La Calhène Group into Getinge's Life Science 
organization – a subdivision of Getinge IC – in order to boost the division’s presence in the pharmaceutical 
industry (Getinge AB 2005). It is also worth to note that La Calhène has been allowed to keep their name and 
brand since being acquired. 
 
4.4 The Integration of La Calhène Into Getinge IC 
According to the interview with Mr. Palmqvist, he describes the acquisition as one in which parts of the sales 
and services department is integrated with the global sales force of Getinge IC, but still retains a sales force 
of its own. In other regards, La Calhène has retained a lot of its autonomy, but with regular financial reports 
and control from Getinge IC. La Calhène has, in this manner, maintained two sales channels. Since its 
integration, the production facility outside Paris has been phased out into being a research and development 
office, with some sales support. The previous sales offices in both Rush City and UK have since been fully 
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integrated in Getinge ICs sales force.  
 
Since La Calhène's integration into Getinge IC also included being included in Getinge IC's Life Science 
department it has had a lot of interaction with that unit on certain levels. The department was founded in 
order to integrate the different competencies of the various firms in the department in order to provide clients 
with something Getinge IC calls “Complete Solutions”, that incorporate all the client’s needs into one offer. 
Complete Solutions, Mr. Palmqvist describes, is a form of consultative sale and generally functions on a 
project level with input from all parts of Getinge IC. He also says that, in general, smaller firms have been 
more concerned with manufacturing on a product level and catering to single needs than complete solutions 
and says that this is one of the things that Getinge AB may bring to the acquired firms. Research and 
development still resides locally at the firm, utilizing their specific competencies of the firm, but is managed 
and guided by this business development function in order to provide complete solutions for the Life Science 
area. The business development function is coordinating the efforts with the managing directors of each local 
company, using input from both sales and research and development. 
 
According to Mr. Palmqvist, La Calhène has an extremely complex and specific product portfolio, which 
makes it difficult to fully integrate the sales force as it requires a lot of education and knowledge about the 
products. In La Calhène's the expertise available at the manufacturing site will have to be brought in for 
certain products, in order to cater to the very specific needs of their clients. Providing this sort of education 
to the entire Getinge ICs sales force would be very expensive, difficult, ineffective and makes no business 
sense. Mr. Palmqvist claims that this has been one of the most difficult aspects of this particular acquisition, 
the complexity of the product and the fact that it is not entirely within Getinge IC's original product portfolio 
makes it difficult for their local sales personnel to incorporate their products in their offer. 
 
While every business unit is responsible for its own bottom-line and its own supply, Getinge IC has made 
efforts towards optimizing the supply-chain-costs for the entire business area through contracts with specific 
suppliers that cover the entire business area. This is done in order to decrease the number of suppliers used to 
give larger quantities to these suppliers. Thus, the orderings are made locally, while the strategic 
development and choices of suppliers is placed centrally in Getinge IC. In this manner, Getinge IC strives to 
rationalize and limit costs by becoming a larger customer with those suppliers, thus strengthening their 
position towards these suppliers. 
 
When it comes to incorporating the specific organizational culture of Getinge AB into La Calhène, Mr. 
Palmqvist states that there have not been any forced attempts at incorporating the Getinge AB culture into La 
Calhène. Rather, the management style and culture of Getinge AB is successively incorporated into the firm 
through the strategic governance and interactions of their local management. In the case of La Calhène, there 
was no extensive exchange of management involved in the take-over.  
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La Calhène was considered to be fully integrated into Getinge IC by the end of 2006, and was specifically 
noted to be contributing to the strong growth of 2007 (Getinge AB 2007b). 
 
In conclusion, Mr Palmqvist says that he considers the acquisition of La Calhène to be a successful 
acquisition, and that the firm is now a natural and well integrated part of Getinge IC and its complete 
solutions offer. The acquisition has rendered La Calhène a growth in sales volume and turnover, remaining 
autonomous under the wings of the Getinge AB, thusly efficiently using the synergies of being part of a 
global corporation. 
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5. ANALYSIS 
 
The following is an in-depth analysis of the empirical evidence  
gathered from the theoretical framework presented in chapter 2.  
The layout is presented as closely to the theoretical framework 
as possible, beginning with an analysis of the MedTech industry, 
followed by an analysis of the structural integration of La  
Calhène. This section is followed by an analysis on the  
informal integration observed and an analysis of the acquisition 
of La Calhène relative other acquisitions undertaken by Getinge AB. 
The chapter is concluded by an analysis of the impacts of the 
industry on acquisitions decisions. 
 
5.1 Industry Analysis 
According to Porter (1979) there are five forces in an industry that explains the competition and the 
relationship between the different stakeholders within the industry, namely the threat of new entrants, threat 
of substitutes, intensity of rivalry, bargaining power of customers and bargaining power of suppliers.  
 
From the empirical findings presented in the previous chapter it is easy to draw the conclusion that the 
MedTech industry is characterized by an intense rivalry (Porter 1979), as there are a lot of firms active on the 
market. The problem with approaching the problem in this manner is that, while the MedTech industry do 
have a lot of firms active, a majority of these firms are not in direct competition with one another. The 
example of the three Swedish firms Gambo, Elekta and Getinge AB provided earlier shows rather accurately 
the nature of the industry, as these firms are all active within the MedTech industry, but produce products for 
very different, specific purposes. The same holds true for several acquisitions undertaken by Getinge AB, 
which will be discussed further in 5.4, with acquisitions as varied as La Calhène, that produces isolators, and 
Kemiterm, that produces distillers and steam generators, which have both been acquired by the Getinge IC 
division. This implies that the MedTech industry should be viewed not as one cohesive industry in this 
regard, but rather as an industry that consists of several smaller industries, in which the competition is not 
very intense. As Huang and Wang (2010) concluded, the intensity of rivalry is rather noted when several 
larger firms attempt to acquire the same firm, than in the individual product competition. This may very well 
be because of the strong tie and dependence the industry has to technology and innovation, as well as the 
complex nature of their products. There are, of course, also firms active with similar products in the same 
specialized industry, but geography is a factor in this, and the competition is based on quality rather than 
costs (Rodewald 2011), which ties it closer to the research and development functions. Therefore, the 
intensity of rivalry is low in regards to products, but medium to high when concerning certain acquisitions 
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and inter-industry activities. 
 
The threat of new competitors on these smaller, specialized markets is fairly low, as the costs of research and 
development on the entire MedTech market is very high, and researching similar technology would be 
extremely costly. The costs of producing these wares are also high, which works as a deterrent for new 
competitors. A trend that is consistent and still important for the industry, however, is that of innovation and 
entrepreneurship, which means that there are still new competitors rising on the industry as a whole with 
new, specialized products in new areas. While these may enter in to the different areas that the existing 
corporations are active in, they are in general not in direct competition with them. The largest threats for the 
larger corporations would rather be the formation of new organizations through the merger of existing 
corporations rather than the entrance of new, small firms. As a whole, the threat of new entrants should be 
considered as medium. While there is a possibility that new small firms may enter the smaller specialized 
markets, the threat is larger than existing firms would merge into a stronger entities, as the MedTech industry 
is not, as of yet, a consolidated one. 
 
The threat of substitutes is a complicated issue in this industry, much as the products in their own right are 
complex, and may come from entirely different industries, as implied by 4.1. A thorough analysis of all 
possible substitutes within the MedTech industry would be very complex and long, and outside the premise 
of this study. To conclude the analysis of the threat of substitutes, the author draws the conclusion that the 
threat of substitutes could be considered medium, as there does exist substitutes and competition on the 
market, but it is far from a consolidated market. 
 
The bargaining power of buyers within the MedTech industry is currently predicted to change within the 
Health Care sector, as the healthcare reform in USA has affected the market (Ernst & Young 2011). The 
holistic viewpoint of suppliers and the tendency to look for healthcare outcomes may give the hospitals 
(buyers) a strengthened standing compared to the suppliers. This implies that the bargaining power of the 
buyer might be increased in this area, and may affect the healthcare sector in the industry as a whole. The 
strength of the suppliers in the MedTech industry could still be regarded to be stronger than that of the 
customers, as there is not overly strong competition, the threat of substitutes is not very high, and the 
products offered by several corporations are fairly unique with limited availability for substitution. The 
disparity between the bargaining power of the suppliers and buyers is not that big, however, but is rather 
close to one another, but the company has a slight overhand over the customers. Therefore, the bargaining 
power of the customers might be considered to be medium to low. 
 
The bargaining power of suppliers for the corporations within the MedTech industry may be regarded as low, 
which is indicated by the inter-firm contracts Getinge AB has made with suppliers in order to lower costs 
through large orders. 
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What is clear from the analysis of the five forces is that the industry is characterized as being fragmented and 
unconsolidated, driven by entrepreneurship and innovation. The role that technology plays in this industry 
cannot be emphasized enough as it is, in its own right, a driving factor for the relationship of the industry. 
Rather than being viewed as a single industry, it might also be considered as a cluster of several smaller 
industries defined by the specific task that the specific product is intended to handle, and substitutes may 
come from entirely different industries than the MedTech industry, such as from drug companies etc. The 
largest threat to the larger companies would appear to be firms of similar size and the threat of them 
acquiring firms that could provide substitutes for their products, rather than the smaller firm manufacturing 
the product. The industry is also characterized by high costs for research and development, and in 
conjunction with the previously mentioned conclusions, it might explain why there is a tendency for 
acquiring firms within the MedTech industry, as it hinders competitors from acquiring the technology that 
might threaten to substitute the firms' own products and because of the high costs of developing that 
technology on their own. 
 
5.2 Analysis of Degree of Integration 
According to Hubbard (2001) there are six primary strategic motives for acquiring a firm, of which the 
author has chosen to implement five, namely; market penetration, market entry, financial synergies, asset 
potential/synergy, and economies of scale.  Judging from the press release previously mentioned (Getinge 
2012) it is easy to draw the conclusions that the motivations for the acquisition was market entry, financial 
synergies and some economies of scales-motives, perhaps even market penetration. This keeps in line with 
the study performed by Leland (2007) that financial synergies are not, on their own merit, a sufficient reason 
for acquiring a firm, but is rather a contributing factor to an acquisitions motive. The interview with Peter 
Palmqvist gives a slightly different picture of the situation, as it shows that market entry, market penetration, 
financial synergy and certain amounts of asset synergy were more likely reasons for acquiring La Calhène. 
Their product portfolio is very specific and covered ranges that Getinge IC had not previously offered their 
customers. Their products was still integrated into a complete solutions offer, which indicate that the motive 
for the acquisition was not merely market entry, but was also affected by market penetration, as it aimed 
towards creating more substantial value for their customers.  
 
The complete solutions offer also provides evidence to support the theory that certain amount of market 
penetration-motivations played a role in the evaluation and acquisition of La Calhène. Of these motivations 
the strongest were probably market entry and market penetration (using Leland's (2007) stance that financial 
synergies are not sufficient for motivating an acquisition) and including the asset synergy motives, we find 
that these three reasons center around change with controls as the most likely degree of integration, from the 
possible financial controls, change with controls and functional integration as displayed in figure 5.1. This 
implies that the degree of structural integration that would follow this type of acquisition should be expected 
to mean some form of restructuring, such as introducing new technology or exchanging the existing 
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management for a new one. 
 
 
 Financial Controls Change With 
Controls 
Functional Integration 
Financial Synergies Likely Possible   
Market Entry Likely Possible Possible 
Asset Synergy Possible Likely Possible 
Market Penetration Possible Possible Likely 
Economies of Scale   Possible  
Figure 5.1 Expected Level of Integration Adapted from figure 2.3 (Nancy Hubbard 2001) 
 
 
The interview with Mr. Palmqvist shows that this is somewhat correct, as the acquired firms' sales force was, 
in part, integrated in to the global sales force of Getinge IC, while still retaining a lot of sales- and support 
functions locally. The interaction between La Calhène and the Life Science department implies a slightly 
deeper connection than merely restructuring, as it involves a substantial interaction between the management 
of La Calhène and the business development function, as well as influencing what direction the research and 
development should take. This leads the author to believe that La Calhène's structural integration has been 
slightly deeper than change with controls, but not as deep as functional integration, as that would imply a 
deeper structural integration of La Calhène's capabilities than has occurred. As further analyzed in section 
5.4, this is likely due to the fact that certain amounts of informal integration has been utilized. The structural 
integration of La Calhène would rather be in between change with controls and functional integration, but 
leaning more heavily towards change with controls. 
 
Taking this in relation to the specific kinds of acquisitions that Huang and Wang (2010) found that Getinge 
AB operates with (namely strategic and bolt-on acquisitions) this would probably lean towards a strategic 
acquisition that requires a lot of thought before being acquired.  
 
The two strategic motives that has not been discussed yet is financial synergies and asset synergy/potential 
(Hubbard 2001). The financial synergies that Getinge AB probably sought to acquire was the ability to utilize 
the global sales force of Getinge IC, alongside of gaining ability to use the cost-synergies that Getinge IC 
had made with several large suppliers in order to lower the costs by becoming a larger customer. The asset 
potential has been briefly touched on, but is, in this case, not used to imply a change of management or 
anything similar to that, but rather to showcase the synergetic possibilities of being part of the Life Science 
department, which allowed for the products of La Calhène to be put in a larger perspective and give La 
Calhène a larger customer-base by being a part of their complete solutions. 
 
While the author expected a higher rate of structural integration between La Calhène and Getinge IC due to 
the market penetration motive, this was not the case. The reasons for this might be that the same motives and 
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required structural integration should not be regarded as a single cohesive motive for all parts of the firm, as 
the market entry motive is more driving concerning manufacturing capabilities and research and 
development. The cost-reduction synergies of integrating the sales force was probably driven by some asset 
synergies motives and market penetration. The structural integration of La Callhène is in a lot of ways 
sufficient for the market entry and asset synergy motives, but both the market penetration and the actual 
coordination of products indicate a higher structural integration. A less complex product might also have 
leant it more easily to a structural integration of the sales- and services department, but with the rigorous 
training required for such a level of structural integration, the costs are likely to outweigh the merits.  
 
5.3 Analysis of Informal Integration 
As concluded in 2.2, Puranam et al. (2009) found that there are certain factors that determine the need a 
corporation has of integrating a firm, and that there are different ways in which this can be done. They 
concluded that the integration (coordination capacity) depended on the need for coordination and the 
interdependence between the firms, and that the coordination capacity consisted of structural integration and 
informal integration (Puranam et al. 2009).  
 
As was concluded in 2.4, the level of integration could be considered to depict the structural integration of 
Puranam et al.'s (2009) theoretical equation (Figure 2.2), and with the analysis from section 5.2 we may 
conclude that the structural integration was limited to certain changes and a follow-up of financial controls as 
well as certain influence on the development of the product portfolio. Seeing as the Life Science division of 
Getinge IC offers complete solutions, in which the products of La Calhène play an integral part, and that the 
business development function of the division jointly plans the development of products, the simple 
assumption of structural integration as the only means of coordination between the acquiring firm and the 
acquired firm is not sufficient. The conclusion is that there is a higher need for coordination between the 
acquiring firm and the acquired firm than is explained by the structural integration part of the theoretical 
model, as La Calhène has not been structurally integrated enough to fill the coordination capacity. The 
conclusion, therefore, is that there is likely to be some form of informal integration, which is common 
ground, used to fill that gap. 
 
The study of Huang and Wang (2010) shows that the cultural management post-acquisition is generally 
handled with a lot of interaction on the managerial levels in order to convey the culture of Getinge AB to the 
acquired firm. Their study and the interview with the Mr. Palmqvist also shows that this is the primary means 
through which Getinge AB conveys culture to the corporations acquired (Huang & Wang 2010), and could 
therefore fill the role of informal integration in the case of La Calhène and Getinge IC.  
 
I have analyzed a few of the reasons why this specific level of structural integration (change with controls) 
was undertaken from what the underlying motives for the acquisition were, but not why deeper structural 
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integration would be unfavorable. As found in 5.1, the role of technology in the MedTech industry is 
extensive and permeates in most facets of the industry and how it functions, and one of the more common 
acquisitions strategies is acquiring firms producing technology previously not within the product portfolio of 
the acquirer. Along with the fact that innovation of new technology is one of the most important facets 
driving the industry, it should not be overlooked and is not covered to a satisfying extent in 5.2. As Puranam 
et al. (2009) found, there is high risk of disrupting the innovative capabilities of the firm and they do not 
recommend the acquisition of stand-alone technology firms to be deeply structurally integrated. 
 
As the Mr. Palmqvist explained, La Calhène's product was not a part of Getinge IC's previous product 
portfolio, which implies that it was what Getinge AB calls a strategic acquisition that involves certain levels 
of risk (Huang & Wang 2010). While this would also imply that the need for coordination and 
interdependence would be low, as it is pretty much a stand-alone product, the fact that it is a part of the 
complete solutions offer of Getinge IC means that there exist higher needs for coordination, as the product 
must be integrated into this offer. This does not necessarily imply any need of structural integration, but 
would require some sort of coordination at the research and development stage. As it was concluded that 
structural integration of this process could hurt these specific capabilities of the firm, these processes would 
need to be integrated informally via common ground integration. As the study of Huang and Wang (2010) 
concluded, this form of informal integration generally occurs at the managerial levels at Getinge AB. This is 
supported by the interview with Mr. Palmqvist, as it is where the integration of La Cahlène and its products 
have occurred. This has been implemented by the managing directors of each firm meeting at Life Science's 
business development function in order to find a common ground and understanding as to what products 
needs to be developed or modified in order to provide the complete solution to the clients' needs. 
 
We can therefore find that this specific quality of Getinge IC (that is the desire to create complete solutions 
for their customers) creates a need to integrate La Calhène to some extent, but that the fact that La Calhène is 
a stand-alone product means that this integration cannot be focused structural integration without risking the 
loss of the innovative process of La Calhène. This therefore creates a need to informally integrate La Calhène 
through the creation of common ground, as the structural integration would be insufficient for the need for 
coordination to be filled. 
 
5.4 Analysis of the Acquisition of La Calhène Relative Getinge AB's Previous 
(and Subsequent) Acquisitions 
In Appendix II the author outlined the acquisitions Getinge AB has partaken in between 1973 and 2009, 
listing some of the probable motives for acquiring the specific firm using press releases and annual reports. 
Among the reasons most commonly presented where market entry, whether entering a new geographical 
market or a new industry. Most likely a larger amount of the acquisitions with a market entry (geographical) 
actually also included the entry into a new industry, but the information is not easy to come by, as a lot of 
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those acquisitions date far back, and several are no longer operating under their previous names, unlike La 
Calhène. In fact, several times that market penetration was listed as a probable reason, it generally also 
meant the acquisition of new technology that previously had not been a part of the products or technology of 
the group. Although asset synergy is only listed as a probable motive in the acquisition of La Calhène, the 
author has reason to believe that it was an important factor in several other acquisitions, as the creation of the 
Life Science department implies, but there is not substantial evidence to support this. Some of these 
acquisitions also lead to consolidation of certain production facilities for the production to be moved to other 
factories, which implies the motive of economies of scale. La Calhène is somewhat special in relation to 
other acquisitions that Getinge AB has undertaken, as it is a very complex product and did not reside in line 
with the previous product portfolio and was therefore difficult to integrate into Getinge IC's sales- and 
service-function. It is, however, fairly similar to the previous acquisitions in other regards. In fact, the 
acquisition of La Calhène is rather similar to one of the more standard practices within the industry, as it is 
marked by a tendency towards technology acquisitions and is rather loosely integrated into the acquirer.  
 
5.5 Analysis of the Impact of Industry on the Acquisition Decisions 
As the analysis in section 5.1 has indicated, the highly technical and innovation-based nature of the MedTech 
industry has immense impact on the decisions in the acquisition-process from what types of firms are 
acquired and why, to the manner in which they are integrated. It also explains why Getinge AB has 
distinguished between bolt-on acquisitions and strategic acquisitions, as the definitions of the World 
Investment Report are more diverse than necessary. Market penetration and vertical expansion are both what 
could be considered bolt-on acquisitions, which involve considerable less risk for the firm, as these 
capabilities are either easily integrated, or are already a part of the owner-specific advantages of the firm, 
while the market entry motives of strategic acquisitions are considerably more risky and differs from the 
previous motive. The sheer amount of acquisitions observed in the industry is also a natural consequence of 
the impact innovation and entrepreneurship have on the industry, as well as the costly process of developing 
products within the industry. This also explains the existence of such a great amount of small firms within 
the industry, as many have been founded on the principles of innovation and entrepreneurship, and the 
acquisition trend of the industry points towards a possible consolidation of the industry. One of the 
underlying factors of this trend is likely the reason that there are a lot of smaller entrepreneurial corporations 
with successful products that lack the financial strength to grow further, and therefore have reasons to want 
to be acquired as well as the firms having motives to acquire them. As the analysis of this chapter indicates, 
the MedTech industry is experiencing change, and there is cause to believe that there might exist a risk of the 
market consolidating in the foreseeable future. 
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6. CONCLUSIONS 
 
This chapter contains the general conclusions drawn from the  
case and answers to the research questions posed in the  
introduction. The chapter then continues to outline the  
theoretical and managerial implications of the case, as well as  
discussing limitations and recommendations for future research. 
Included is also a discussion on certain points that was not  
observed in the case study, and a discussion as to why these  
points where not observed. 
 
6.1 General Conclusion 
With a basis in the problem discussion and the theoretical framework placed concerning the field of interest, 
to analyze the ways in which a corporation implements and integrates an acquisition and what the role 
industry has in the underlying decisions, three research questions were formulated. By studying the facts and 
analysis of the case of the acquisition of La Calhène the following conclusions could be drawn: 
 
6.1.1 RQ1: How does the MedTech industry affect the acquisition in the case of 
Getinge AB and La Calhène? 
The role of the industry characteristics seems to have a large impact on how acquisitions are conducted, why 
they are undertaken and to what extent they are used. The MedTech is, for one, characterized by a large 
amount of acquisitions being undertaken, and it is not uncommon for a firm to undertake several acquisitions 
in same year, examples of which would be Getinge AB's eight acquisitions of 1998. The amount of small 
firms seems to be the cause of this, as it indicates the opportunity to acquire a greater variety of firms with 
less financial risk than acquisitions in; for example, the automotive industry would experience. As Puranam 
et al. (2009) concluded, the impact of technology on the acquisition decision is a decisive factor, and an 
industry in which the acquisition of technology is more common this will greatly impact the decisions taken. 
The industry will therefore also impact the leniency towards either structural or informal integration, where a 
fragmented industry driven by technology will lean towards informal integration rather than structural in the 
cases of the acquisition of stand-alone products, as the likelihood for technology acquisitions would be 
increased compared to a consolidated industry.  
 
The MedTech industry’s effects on the decisions taken in the case described are extensive, as the diverse 
nature of the industry lends itself to a higher extent of stand-alone acquisitions than might be observed in 
other industries. The shift towards healthcare outcomes and consolidation also supports an increase in 
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complete solutions offers, and therefore a higher extent of acquisitions of this kind. The technological nature 
of the industry also impacts the specific acquisition, as it was difficult to structurally integrate La Calhène, 
and the informal integration route was therefore necessary. The MedTech industry did therefore affect the 
specific acquisition in three ways; 1) a slow consolidation means that acquisitions are easier to undertake 
than in a consolidated industry; 2) the high technological nature of the industry makes deep structural 
integration more difficult to undertake; and 3) the drive for health care outcomes drives a need for informal 
integration in order to offer complete solutions to the customers. 
 
6.1.2 RQ2: What capabilities of La Calhène are integrated Getinge AB, and why? 
As the most important strategic (again differing from personal and political motivations) motive for 
acquiring another firm is that the acquiring firm believes that it can utilize the capabilities or synergies of 
some form of the firm more efficiently than the firm could autonomously, the logical conclusion is that the 
capabilities integrated would be those that create greater value from being integrated. This is, however, a 
very simplistic way of answering the posed question and does not give a sufficient answer to it. 
 
The integration of value-creating capabilities may be referred to as structural integration (Puranam et al. 
2009), and is dependent on the motives behind the acquisition. Nancy Hubbard (2001) named six strategic 
motives behind acquiring a firm determining the subsequent integration; market penetration, vertical 
expansion, financial synergies, market entry, asset potential/synergy and economies of scale. Each of these is 
then correlated with likely, probable and unlikely levels of integration in figure 2.3 (financial controls, 
restructuring with controls, functional integration or total integration (Hubbard 2001)). Why certain 
capabilities are integrated are dependent on the underlying motives and the need for coordination (Puranam 
et al. 2009) but are also dependent on the informal integration chosen.  
 
In the case of Getinge AB and La Calhène, the only structural integration that took place was a restructuring 
of the sales force that rationalized a small amount of the sales force (primarily UK and parts of the USA sales 
force) and certain coordination on the managerial level, based on the fact that further structural integration of 
the sales force would cost more than the firm would gain due to economies of scale and would result in an 
ineffective sales force. The reason why no further integration was undertaken was due to it being a pure 
technology acquisition of a stand-alone product in which further structural integration might very well harm 
the innovative competitive factors that is important in the industry (Puranam et al. 2009). The risk of 
disrupting the research and development processes and loosing technical competencies would make it foolish 
to integrate these processes or place further restrictions on the acquired firm. The reason for this was because 
the strongest motives were market entry and penetration, wishing to acquire certain technical competencies 
and products as well as research and development processes (Gendron 2004).  
 
Getinge AB appears to be falling in line with the expected structural integration to some levels, but the level 
of cooperation within the Life Science department and the complete solutions offer is not explained strictly 
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by structural integration, that is the integration of capabilities. There is therefore a need to analyze further 
aspects than is covered by Hubbard's model. 
 
6.1.3 RQ2: How does Getinge AB integrate La Calhène? 
According to Puranam et al. (2009) the acquiring firm can integrate an acquired firm through either 
structural integration or informal integration (common ground), where the latter can be more closely related 
to cultural factors. The structural integration is defined by Nancy Hubbard (2001) to be one of four (financial 
controls, restructuring with controls, functional integration or total integration) that define the degree of 
autonomy the acquired firm enjoys from the acquiring firm. In Getinge AB, these two different means of 
integrating and coordinating the acquired firm may be linked to one of two types of acquisitions; strategic 
and bolt-on (Huang & Wang 2010), which, in turn, are a simplified version of the three types of acquisitions 
defined by the World Investment Report (2000); vertical expansion, horizontal acquisition and conglomerate 
acquisition (strategic). Huang and Wang (2010) went on to conclude that this was likely a more practical 
approach. This study show that the strategic acquisition has more akin with informal integration (though 
exceptions may exist), while bolt-on may be linked to a greater degree of structural integration.  
 
The decision to integrate the firm is, however, dependent on how large the need for coordination (Puranam et 
al. 2009) is, which is dependent on the underlying motives for the acquisition. While Hubbard's (2001) 
model (figure 2.3) only shows the structural integration required to reach the need for coordination, it fails to 
address the informal integration that should accompany this structural integration. The market penetration 
sought in the case of the acquisition of La Calhène, for example, required certain informal integration steps 
as well, with the exchange of culture and coordination with other managing directors within the Life Science 
department, and the market penetration motive that acted as one of the reasons to acquire required additional 
informal integration to function efficiently (seeing as market penetration's most likely degree of integration 
required would be functional integration, which was not observed). The study of Huang and Wang (2010) 
also shows that the informal integration occurs on the managerial level, which is also supported by the 
interview with Peter Palmqvist, which describes the coordination within the Life Science department. The 
coordination does not, however, fully explain the integration of La Calhène, as the integration of the 
managerial level within the Life Science department is neither fully an increase in structural integration or 
informal integration, rather being something in the middle, where the structural integration is slightly above 
restructuring with controls, as the informal coordination alone does not fill the gap between the need for 
coordination and the level of coordination with restructuring implies. 
 
The conclusion is therefore that Getinge AB integrates La Calhène both structurally and informally, 
integrating it structurally into their organizational network to some extent as well as through the integration 
of certain sales functions, and informally through a certain spread of culture and coordination through 
business development and similar functions. The conclusion of the case study is therefore that both structural 
and informal integration was required in order to fill the coordination capacity and realize the synergies 
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sought by the motives of market entry and market penetration. 
 
6.3 Managerial implications 
Theory does not generally reflect reality perfectly, and the understanding of the underlying processes may 
not impact on the process itself, but knowledge about it may offer a path to reach better solutions than would 
have been reached uninformed. Knowing and being able to pinpoint the specific reasons for wishing to 
acquire a certain corporation will help a corporation to find the required amount of work that will have to 
take place in order to structurally integrate the firm to a proper degree in order to reach the desired synergies 
of the new entity. Knowing what place the product portfolio of the acquired firm will have in the new entity 
will also aid in understanding how much informal integration will have to take place in order to fill the need 
required for such a degree of integration. Understanding the nature of the industry will also help 
understanding certain limitations and risks that may be involved in the acquisitions process, and how to 
avoid these specific risks when taking decisions as to the level of structural post-acquisition integration to be 
taken. 
 
6.4 Recommendations For Future Research 
Further studies within this field is recommended in order to acquire a deeper and clearer understanding of the 
process of mergers and acquisitions and further emphasize the importance of proper understanding of this 
field when in the decision-making process. Subsequent research should either be broadened to map this type 
of acquisition in several industries, or tilted to show the polar opposite of this type of acquisition in the 
MedTech industry – that is either a failed acquisition or a fully merged acquisition. The following is a 
summary of suggested further areas of research: 
 
A study involving several acquisitions of either the same type or industry, or, preferably, both. The analysis 
of a few acquisitions in two industries with differing dependence on innovation and technology would be 
recommended.  
 
A study diversifying the levels of integration that may be observed between two firms, accounting for this 
project-based form of structural integration between autonomous firms observed in this study, and finding 
the cause of why this is observed. 
 
Another instance in which further research would be recommended is within the asset potential/synergy 
motive of an underlying acquisition, as it currently is tilted towards the replacement of management, while 
the practical reality observed in the acquisition of La Calhène is the reason of coordinating the technology 
into a complete solutions offer. A larger emphasis on this type of semi-informal semi-structural integration 
would be recommended. 
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6.4.1 Why No Significant Problems were observed 
In the start of the process of gathering information and approaching the problem of this case-study, I initially 
posed a fourth research question: what problems arise when integrating and coordinating the acquired firm 
within the existing organizational hierarchy. This question was removed from the finalized version of this 
dissertation, as there hadn't really been any observed problems that would warrant further analysis and 
discussion than already warranted by the previous three research questions. It is still an interesting side-note, 
however. The only problem that was observed during the integration and coordination of La Calhène was the 
difficulty of integrating the sales force, which was due to its complex technical nature, and due to the fact 
that the greatest extent of integration was informal. The autonomy of La Calhène is probably the reason why 
this is the only problem of integration noted, as the only level were integration and coordination occurred in 
any significant amount was on the managerial levels. Therefore, the reliance on informal integration on the 
managerial levels in a friendly acquisition should not lead to serious problems, which makes the initial 
question posed irrelevant for the specific case. 
 
 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
46 
 
 
 
7. REFERENCES 
 
 
Amiryany N., Huysman M., de Man A., Cloodt M., 2012. Acquisition reconfiguration capability. European 
Journal of Innovation Management, 15( 2),  pp 177-191. 
 
Arndt M., Thornton E., Foust D., 2000. Let’s talk turkey: Some mergers were never meant to be. Business 
Week, 44. 
 
Bio-Medicine, 2007. New report finds great potential for Swedish medical technology. [online] Available at: 
<http://wwww.bio-medicine.org/biology-news-1/New-report-finds-great-potential-for-Swedish-
medical-technology-1623-1/>[Accessed 16 May 2012]. 
 
Business Library. 1996.  MDT corporation announces agreement to be acquired and reports preliminary 
fourth quarter and fiscal year results. [online] Available at: 
<http://findarticles.com/p/articles/mi_m0EIN/is_1996_May_12/ai_18276812/?tag=content;col1> 
[Accessed 16 May 2012].  
 
Dawson P., 1994. Organizational change: A processual approach. London: Paul Chapman. 
 
Elekta AB, 2011. Elekta annual report 2010/11.: Elekta AB 
 
Elekta AB. Who are we. [online] Available at: <http://www.elekta.com/company/about.html> [Accessed 
16 May 2012]. 
 
Ernst & Young, 2010. Pulse of the industry: Medical technology report 2010. [pdf] Ernst & Young. Available 
at: <http://www.thehealthcareinvestor.com/uploads/file/E&Y%20Medtech%20Report.pdf> 
[Accessed 16 May 2012].  
 
Ernst & Young, 2011. Global MedTech industry emerging from global recession. [online] Available at: 
<http://www.ey.com/GL/en/Newsroom/News-releases/Press-release_Global-medtech-industry-
emerging-from-global-recession> [Accessed 16 May 2012].  
 
Fahlén S., 2007. Venture capital for Swedish MedTech entrepreneurship: an analysis of how well the Swedish 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
47 
 
venture capitalists correspond to the needs of the Swedish med tech entrepreneurs. M.Sc. Kungliga Tekniska 
Högskolan (Royal Institute of Technology). 
 
Feldman M., Spratt M., 1999.  Five frogs on a log: A CEO's field guide to Accelerating the Transition in 
Mergers, Acquisitions, and Gut Wrenching Change. New York: HarperBusiness. 
 
Fisher C. et al., 2nd ed., 2007. Researching and writing a dissertation: A guidebook for business students. 
Harlow: Pearson Education Limited. 
 
Fletcher, R., Barrett, N. (2007). Acquisition as a Phase in Internationalization- The End of the Road or a 
New Beginning.[pdf] Available at: <http://www.impgroup.org/uploads/papers/178.pdf> [Accessed 16 
May 2012].  
 
Fralicx R., Bolster C., 1997. Preventing cultural shock. Modern Healthcare, 27 (32) p. 50. 
 
Gambro AB, 2011a. Gambro in brief. [online] Available at: <http://www.gambro.com/en/global/About-
Gambro/Gambro-in-brief/> [Accessed 16 May 2012]. 
 
Gambro AB, 2011b. The Gambro story. [online] Available at: <http://www.gambro.com/en/global/About-
Gambro/The-Gambro-story/> [Accessed 16 May 2012].  
 
Gendron M., 2004. Integrating newly merged organizations. London: Praeger Publishers. 
 
Getinge AB, 2000a. Getinge acquire Parker Bath – and good growth with synergy. [online] Avaialble at: 
<http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-acquires-Parker-Bath---and-
good-growth-synergy/> [Accessed 16 May 2012].  
 
Getinge AB, 2000b. Getinge acquirers Key Distributor in Ireland. [online] Available at: 
<http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-acquires-Key-Distributor-
in-Ireland/> [Accessed 16 May 2012]. 
 
Getinge AB, 2000c. Getinge acquires Maquet – global leader in surgical tables – as a platform for a new 
business area with significant growth. [online] Available at: 
<http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-acquires-Maquet---global-
leader-in-surgical-tables---as-platform-for-a-new-business-area-with-significant-growth/> [Accessed 
16 May 2012]. 
 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
48 
 
Getinge AB, 2000d. Getinge Industrier AB, annual report 2000.: Getinge AB. 
 
Getinge AB, 2000e. Getinge makes strategic acquisition with significant growth potential. [online] Available 
at: <http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-makes-strategic-
acquisition-with-significant-growth-potential/> [Accessed 16 May 2012].  
 
Getinge AB, 2001. Getinge acquires ALM – world leader in surgical lighting systems. [online] Available at: 
<http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-acquires-ALM---world-
leader-in-surgical-lighting-systems/> [Accessed 16 May 2012]. 
 
Getinge AB, 2004. Getinge acquires leading manufacturer of ceiling hoist lifters. [online] Available at: 
<http://www.getingegroup.com/en/Press/Press-releases-Active/Getinge-acquires-leading-
manufacturer-of-Ceiling-Hoist-Lifters/> [Accessed 16 May 2012].  
 
Getinge AB, 2005. Getinge acquires world-leading supplier to the Life Science industry. [online] Available 
at: <http://www.getingegroup.com/en/press/Press-releases-Active/Getinge-acquires-world-leading-
supplier-to-the-Life-Science-industry/> [Accessed 16 May 2012]. 
 
Getinge AB, 2006. Getinge acquires world-leading supplier to the life science industry. [online] Available at: 
<http://www.getinge.com/documentPage.aspx?type=9&documentId=115921643577&languageID=
1> [Accessed 16 May 2012].  
 
Getinge AB, 2007a. Getinge significantly expands in area of cardiac and vascular surgery, and creating 
platform for new growth. [online] Available at: <http://www.getingegroup.com/en/press/Press-releases-
Active/Getinge-significantly-expands-in-area-of-cardiac-and-vascular-surgery-and-creating-
platform-for-new-growth/> [Accessed 16 May 2012].  
 
Getingh AB, 2007b. Getinge AB Delårsrapport 2007. [pdf] Available at:< 
http://www.getingegroup.com/Global/Reports/Interim%20Reports%202007/Delarsrapport0706SE.pdf> 
[Accessed 4 June 2012]. 
 
Getinge AB, 2008. Getinge continues to strengthen its presence in the cardiovascular market, through the 
acquisition of Datacorp.[online] Available at: <http://www.getingegroup.com/en/press/Press-releases-
Active/Getinge-continues-to-strengthen-its-presence-in-the-cardiovascular-market-through-the-
acquisition-of-Datascope-Corp/> [Accessed 16 May 2012]. 
 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
49 
 
Getinge AB, 2012a. Getinge Vision Statement. [online] Available at: 
<http://www.getinge.com/sectionPage.aspx?m1=115028465220&m2=115028535258&wsectionID=
115028535258&languageID=1> [Accessed 16 May 2012].  
 
Getinge AB, 2012b. History. [online] Available at: <http://www.getingegroup.com/en/About-Getinge-
Group-name/History/> [Accessed 16 May 2012].  
 
Getinge AB, 2012c. Our Customer Segments. [online] Available at: 
<http://www.getinge.com/sectionPage.aspx?m1=115028465220&m2=115028952225&wsectionID=
115028952225&languageID=1> [Accessed 16 May 2012].  
 
Getinge Asia, 2012. 100 years of Getinge. [online] Available at: <http://www.getingeasia.com/about-
us/100-years-of-getinge> [Accessed 16 May 2012]. 
 
Getinge Group, 2010. Getinge AB annual report 2010: Getinge AB 
 
Getinge La Calhéne, 2012a. Application and products. [online] Available at: <http://www.getinge-
lacalhene.com/products/home.cfm?m=products> [Accessed 16 May 2012].  
 
Getinge La Calhène, 2012b. Nuclear. [online] Available at: <http://www.getinge-
lacalhene.com/products/nuclear_home.cfm?m=products&sm=nuclear> [Accessed 16 May 2012].  
 
Getinge La Calhène, 2012c. News. [online] Available at: <http://www.getinge-
lacalhene.com/company/news.cfm> [Accessed 16 May 2012]. 
 
Graebner M., 2004. Momentum and serendipity: how acquired leaders create value in the integration of 
technology firms. Strategic Management Journal. 25, pp 751-777. 
 
Hofstede G., 1997. National culture dimensions. [online] Available at: <http://geert-
hofstede.com/national-culture.html> [Accessed 16 May 2012].  
 
Huang J., Wang H., 2010. Internationalization through acquisition: A case study of Getinge AB. M.Sc. 
Högskolan Halmstad (Univeristy of Halmstad). 
 
Hubbard N., Rev. ed, 2001. Acquisitions: Strategy and implementation. London: PALGRAVE. 
 
Hunt J., Turner D., 1987. Hidden Extras: How people get overlooked in take-overs. Personell Management. 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
50 
 
19(7), pp  24-26, 28. 
 
Jennings, O., 1985. Preventing acquisition failures. Management Review, 74(9), pp 37-39. 
 
Kitchin, J., 1967. Why do mergers miscarry?.  Harvard Business Review. 45(6), pp 84-101. 
 
KPMG Management Consulting, 1999. Unlocking shareholder value: The keys to success – mergers & 
acquisitions – a global research report. London: KPMG. 
 
Lavoie B., Pain L., 2010. Hospitals apply surgical precision to budgets, brace to support healthcare reform. 
[pdf] L.E.K. Consuling. Available at: <http://www.lek.com/sites/default/files/lek-
hospitals_apply_surgical_precision_to_budgets_brace_to_support_healthcare_reform.pdf> 
[Accessed 16 Mat 2012]. 
 
Leland H., 2007. Financial synergies and the optimal scope of the firm: Implications for mergers, spinoffs, 
and structured finance. The Journal of Finance, 62 (2), pp 765-807 
 
Lohrum C., 1996. Post-acquisition integration: Towards an understanding of employee reaction. Ph.D. 
Svenska Handelshögskolan. 
 
Olsson, B., 1999. Aftonbladet nyheter: Ford köper Volvo. Aftonbladet, [online] 28 January. Available at: 
<http://wwwc.aftonbladet.se/nyheter/9901/28/volvodetroit.html> [Accessed 4 June 2012]. 
 
Orminadhi O., Stringa O., 2008. Porter's model of generic competitive strategies. Business Economics, 4(3), 
pp 55-64. 
 
Pablo A., 1994. Determinants of acquisition integration: A decision-making perspective. Academy of 
Management Journal, 37(4), pp803-836. 
 
Porter M., 1979, reissue 2008. The five forces that shape strategy. Harvard Business Review. 86(1), pp 78-
93. 
 
Puranam P., Singh H., Chaudhuri S., 2009. Integrating acquired capabilities: When structural integration is 
(un) necessary. Organization Science, 20(2) pp 313-328. 
 
Rodewald T., 2011. Growing competition in MedTech space more about quality than cost. Medical Device 
and Diagnostic Industry [online]. Available at: < http://www.mddionline.com/blog/devicetalk/growing-
competition-medtech-space-more-about-quality-cost> [Accessed 16 May 2012]. 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
51 
 
 
UNCTAD, 2000. World investment report 2000: Cross-border mergers and acquisitions and development. 
New York & Geneva: UNCTAD 
 
Yin, R., 4
th
 ed., 2009. Case study research – design and methods; Applied social research methods series. 
Thousand Oaks: Sage Publications. 
 
 
Integrating Acquisitions: The Case of La Calhène and Getinge Infection Control  
52 
 
 
 
APPENDIX I: INTERVIEW GUIDE 
 
A: Face Sheet Questions: 
1: What is your role (not title) at the company? 
 
2: In what field would you say that you have the most experience? 
 
3: Do you have any international working experience? 
 
B: Getinge Infection Control and Acquisitions: 
1: Getinge Infection Control have a wide amount of business areas. Which would you say is the  
 
2: Why do you think your corporation has partaken in so many acquisitions? 
 
3: Who chooses what firms are to be acquire, and who is responsible for implementing the 
acquisitions? 
 
4: What steps have Getinge Infection Control in general taken to optimize your production 
capabilities in regards to your acquisitions? 
 
6: How do Getinge follow-up on an acquisition to assess its success? 
 
C: Acquisition of La Cahlène: 
7: How has the integration of La Calhène into Infection Control gone? 
 
8: What functions of La Calhène has, seven years later, actually been integrated in to Infection 
Control, and what functions are still divided from the other parts of the operation? Are RnD-
activities still conducted by the firm individually? 
 
 
9: What steps has Infection Control taken in order to further integrate La Calhène? 
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10: What functions have been integrated into the Life Sciences division of Infection Control? How 
is the relationship between La Calhène and that division? 
 
11: Do Infection Control and La Calhène share a joint supply chain? To what extent? 
 
12: Getinge Infection Control proudly states on your website that Infection Control excels in 
integrating your products into a single comprehensive offer that covers all aspects the customer 
desires. What role do the products of La Calhène play in that offer? Are the products of your 
subsidiaries developed with the distinct purpose of integrating them, or are the integration of them 
handled on a central level? 
 
13: What aspects have been most complicated in integrating La Calhène? 
 
14: How would you describe the relationship between the management of La Calhène and Infection 
Control? 
 
15: Do you consider the acquisition of La Calhène to have proven to be a successful acquisition? 
On what grounds? 
 
D: Cultural Issues: 
15: How would you describe the corporate culture of Getinge? 
 
16: Since Getinge is such a nationally diverse firm I would like to know if the issue of culture has 
been perceived as a problem or threat to the corporation? 
 
17: How do you deal with cultural issues, should they arise? Do Getinge have a set policy for such 
events? 
 
18: Are the cultural aspects problematic in communication with the executives and employees at La 
Calhène? 
 
19: Have you (Getinge) made steps to integrate the corporate culture of Getinge into La Calhène? 
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APPENDIX II: GETINGE’S ACQUISITIONS 
 
The following is a chart covering the acquisitions Getinge has partaken in, and, when available from 
accessible sources, clarifying the motive behind the acquisitions to the extent as possible starting 1973 when 
the first acquisition was made up until 2009. Years worthy of notice are 1964 when Getinge was acquired by 
Electrolux, and 1989 when it was acquired by Carl Bennet and Rune Andersson. 
 
Acquisition Year Business Area Probable Motive for Acquisition 
Vaxjö Rostfritt 1973 Disinfection Market entry, market penetration 
CTC  1973 Autoclaves Market entry, market penetration 
Sterilizing 
equipment 
company 
1975 Sterilizing Market entry 
Lequeux 1981 - Market entry (geographical) 
Fred Clark Pty 1983 - Market entry (geographical) 
ZK Hospital 1985 - - 
Scott Western 1990 Disinfection Market Entry (geographical industry) 
Britsh Sterilizer 1993 Sterilization Market Entry (Geographical) 
Stirn Industries 1993 Disinfection  Market Entry (Geographical), Economies of 
Scale 
Lancer 1994 Disinfection Market Penetration, Economies of Scale 
Arjo 1995 Hygiene, patient 
handling 
Market Entry (New industry) 
Anzy Sterilizers 1995 Hospital Sterilization Market Entry (Geographical) 
Lic Care (now 
Lifco) 
1995 Distribution Vertical Expansion 
Peristel 1995 Hospital Sterilization Market Entry (Geographical) 
MDT Corporation 1996 Sterilization Market Entry (Geographical), Economies of 
Scale 
Kemiterm 1998 Autoclaves, etc. Market Penetration, economies of scale,  
MTP 1998 Disinfection Economies of scale, Market Penetration 
Omasa 1998 Sterilization Market Entry (Geographical) 
Royal Linden 1998 Sterilization Market Entry (Geographical) 
SMI/BBC 1998 Sterilization Market Penetration, Economies of Scale 
Pegasus 1998 Patient handling Market entry (industry) 
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Egerton 1998 Patient handling Asset synergy, economies of scale, Market 
penetration 
Medibol 1998 Patient handling Market entry (Geographical),  
Parker Bath 2000 Patient handling Market entry (Industry) 
Lenken 
Healthcare 
2000 Distribution Vertical expansion 
Gestion Techno-
Mèdic 
2000 Hygiene Market Entry (new industry) 
Maquet 2000 Surgical Systems Market Entry (New industry), economies of 
scale, Market Penetration 
ALM 2001 Surgical Lightings 
systems 
Economies of scale, Market Entry (new 
industry) 
Heraeus 2002 Medical systems Market Penetration, product portfolio 
diversification 
Siemens LSS 2003 Ventilators Market entry 
Jostra 2003 Open-heart surgery 
equipment 
Market Penetration, Market Entry 
BHM 2004 Patient handling Market penetration, Market entry (new 
industry) 
La Calhène 
Group 
2005 Sterilization Market Entry (New industry), Market 
Penetration, (Asset Synergy) 
(agent in Czech 
republic) 
2006 - Vertical Expansion 
MEDICAL 
SYSTEM 
COMÉCIO E 
OMDÚSTRIA 
MÉDICA LTDA 
2006 Cardiopulmonary Market penetration 
OTY GMBH 2006 Tele-medicine Market Entry (new industry) 
Huntleigh 
Technology PLC 
2007 Patient handling Market Penetration, Economies of Scale 
Boston Scientific 
Corporation, 
divisons: Cardiac 
and Vascualar 
surgery 
2008 Surgical instruments Market Entry (New industry) 
Datascope 
Corporation 
2009 Surgical instruments Market penetration, economies of scale. 
Table 4.1: Getinge's Acquisitions between 1973 and 2009. 
Sources: Getinge Annual Reports (1998, 1999); Getinge AB 2000a-c, e;Getinge AB 2001; Getinge 
AB 2004; Getinge AB 2005; Getinge AB 2006; Getinge AB 2007; Getinge AB 2008; Getinge AB 
2012;Getinge Asia 2012;  Business Library 1996 
 
Information in the column “probable motive for acquisition” was determined based on the stated needs of 
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integration and acquisitions-motives found in press-releases, the relocation of production capabilities that 
followed, and the product portfolio of the specific acquisition. In instances where this kind of information 
was scarce assumptions have been drawn using exclusively the Getinge corporate website outlining the 
company’s historical progression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
